Quantitative trait variation and adaptation in contemporary humans by Mostafavi, Hakhamanesh
Quantitative trait variation and
adaptation in contemporary humans
Hakhamanesh Mostafavi
Submitted in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy







Quantitative trait variation and adaptation in contemporary humans
Hakhamanesh Mostafavi
Human genomic data sets are now reaching sample sizes on the order of hundreds
of thousands and soon exceeding millions, providing unprecedented opportunities to
understand human evolution. Most studies of human adaptation so far have focused
on selection that has acted over the past million to few thousand years. However,
powered by large data sets, it is now feasible to study allele frequency changes that
occur within the short timescale of a few generations, directly observing selection act-
ing in contemporary humans. I take this approach in the work presented in Chapter
1 of this thesis, where we performed a genome-wide scan to identify a set of genetic
variants that influence age-specific mortality in present-day samples. Our findings
include two variants in the APOE and CHRNA3 loci, as well as sets of variants
contributing to a number of traits, including coronary artery disease and cholesterol
levels, and intriguingly, to timing of puberty and child birth.
New research directions have also opened up with the advent of large-scale
genome-wide association studies (GWAS), which have begun to uncover genetic vari-
ants underlying a number of human traits, ranging from disease susceptibility to
social and behavioral traits such as educational attainment and neuroticism. One
such direction is the use of polygenic scores (PGS), which aggregate GWAS findings
into one score as a measure of genetic propensity for traits, for phenotypic prediction.
A major obstacle to this application is that the prediction accuracy of PGS drops in
samples that have a different genetic ancestry than the GWAS sample. Our work,
presented in Chapter 2, demonstrates that PGS prediction accuracy is also variable
within genetic ancestries depending on factors such as age, sex, and socioeconomic
status, as well as GWAS study design. These findings have important implications
for the increasing use of these measures in diverse disciplines such as social sciences
and human genetics.
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Since emerging 200,000 years ago in Africa, modern humans have populated the
globe in a relatively short amount of time [1], which required being able to adapt
to a diverse range of environments (e.g., with respect to sunlight exposure, diet,
climate)[2]. Furthermore, changes in life-style brought about new challenges, e.g.,
spread of infectious diseases with increased population densities facilitated by the
transitioning from hunter-gathering to farming. Understanding to what extent the
genetic variation segregating in humans is shaped by such selection pressures versus
neutral evolutionary processes has been a long-standing goal of human evolutionary
biology.
With the availability of large human data sets made possible by the advances in
the genome sequencing and genotyping technologies over the past twenty years, sev-
eral statistical methods have been developed to use polymorphism data to detect the
footprint of past adaption events in the genome of present-day humans. Almost all
early efforts focused on strong positive selection at a single locus, namely a “selective
sweep”, where an advantageous mutation rapidly rises in frequency in the popula-
tion [3, 4]. Compelling examples of human adaption were identified by searching the
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genome for signatures of selective sweeps, notably for mutations underlying adapta-
tion to diet, altitude, skin pigmentation, and pathogen resistance (e.g., [5, 6, 7, 8]).
However, later studies demonstrated that strong selection at single-locus level did
not make a large contribution in shaping the genetic variation landscape in modern
humans [9, 10]. These findings led to the realization that selection on polygenic traits
acting simultaneously at several loci, i.e., “polygenic selection”, would induce small
shifts in allele frequency at trait-associated loci that are missed by methods designed
to detect large allele frequency changes at a single locus, and motivated a shift in
focus to understanding and detecting this form of selection [11].
With the advent of large-scale genome-wide association studies (GWAS), we are
now beginning to uncover the genetic architecture of many human traits [12]. GWAS
scan the genome for association with a trait by regressing phenotypic values on geno-
types, typically one locus at a time [13]. A major finding is that most traits of interest
are highly polygenic, influenced by hundreds to thousands of loci distributed across
the genome [14, 15, 16]. For example, Yengo et al. identified 1,185 SNPs (single
nucleotide polymorphisms) associated with human height [17]; Boyle et al. estimated
that there are >100,000 SNPs in the genome with causal effect on height [14].
The first use of GWAS findings in order to test for polygenic selection in humans
was reported for height in Europe, where Turchin et al. showed that height increas-
ing alleles have systematically higher frequencies in Northern Europeans compared
to Southern Europeans that is not explained by genetic drift alone [18]. Signature of
polygenic selection for height was also detected with more sophisticated approaches,
notably by Berg and Coop, who formulated a null model for the dispersion of poly-
2
genic scores (PGS, which for a given trait represent the genetic predisposition by
aggregating the effect of many trait-associated loci into one score, see below) across
populations under genetic drift [19], and by Field et al., who developed a method
based on a signature of genetic diversity around trait-associated SNPs that is sensi-
tive to more recent selection events (during the past 2,000-3,000 years) [20]. Moreover,
signals were detected for other traits, such as BMI, age at menarche, and infant head
circumference, suggesting that polygenic selection may have been the abundant mode
of adaptation in humans [20, 19, 21, 22]. The validity of these signals, however, have
been recently revisited (see below).
Studies of past adaptation using present-day populations suffer from two major
limitations: (i) they are by design indirect and based on specific models of adapta-
tion (e.g., selective sweeps) and therefore may provide a limited and biased view of
human adaptation. (ii) They do not provide information about the component of
evolutionary fitness that loci underlying adaptation affected; even for well-studied
examples, such as LCT mutations associated with lactose tolerances, it remains un-
clear whether they were selected because they provided an advantage for survival,
fecundity, or inclusive fitness (the ability of individuals to impact the fitness of their
kin) [23]. With the advent of large genomic data sets, however, it is now becoming
feasible to study natural selection directly in present-day samples, with the further
ability to disentangle the effects on fitness components (by collecting information on
number of children, lifespan, number of grandchildren, etc.).
Remarkably, the first known target of selection in humans, the sickle cell allele,
was identified by Allison through direct observation of its effect on survival in malaria-
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endemic regions [24]. The sickle cell allele is an extreme example however, and most
effects on fitness are likely much smaller, notably for variants underlying polygenic
selection. Directly observing small evolutionary change within a few generations thus
requires huge sample sizes which were not available until the last few years.
In the work presented in Chapter 1, we focused on the viability component of
fitness in contemporary samples that are directly observable [25]. We used two large
data sets, the GERA cohort in California [26, 27] and the UK Biobank [28], to look for
variants that affect age-specific mortality. We tested whether the frequency of genetic
variants changed with age of the individuals in these data sets (or by proxy with the
age at death of their parents) more than expected by chance, after controlling for
ancestry differences across age cohorts. We found two variants across the genome:
the 4 allele of the APOE gene, a major risk factor for Alzheimer’s disease, and
a variant in the CHRNA3 locus previously shown to be associated with smoking
behavior. To observe only two common variants with large effect on survival even
when they exert their effect late in life (despite having enough power to detect such
variants) was surprising to us, considering that prevalent theories of aging predict an
accumulation of harmful genetic effects post reproductive age. Our findings suggest
that either (i) late-onset variants have been kept at low frequency by selection, and
so are not neutrally evolving as typically assumed, or (ii) the mutational target size
for variants with only late-acting effects is tiny. If (i) is true, it raises the question
of why APOE and CHRNA3 variants are common. We hypothesize that they either
became harmful recently (e.g., for CHRNA3 variants as a result of increased cigarette
smoking prevalence), or they provided a fecundity or early-onset survival advantage
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in ancestral environments.
Considering the polygenic nature of most human traits, we extended our approach
to test for the collective effect of sets of genetic variants previously identified in GWAS.
To this end, we constructed PGS for 42 traits and investigated whether these scores
vary by age. We found associations for a number of traits, e.g., for coronary artery
disease (CAD), BMI, cholesterol levels. Intriguingly, we found a negative association
between longer lifespan and variants delaying the age at puberty and age at first child
birth, possibly reflecting a trade-off between longevity and fecundity. These findings
underscore the importance of studying fitness components separately (e.g., this work),
complementing the approaches that aim to infer the net effect of genetic variants
(e.g., by looking at lifetime reproductive success, e.g., [29, 30, 31]). We also identified
age effects that were different in males and females, notably for variants associated
with CAD and cholesterol levels. These results further suggest that human viability
is extremely polygenic and potentially more variants will be found with increasing
sample sizes; for instance, a recent GWAS of parental lifespan with about 1 million
samples identified 12 genome-wide significant loci (compared to two in our study)
[32].
Our results presented in Chapter 1 serve as a proof-of-concept that genetic data
sets are becoming large enough such that we can begin to study the ongoing natural
selection in humans. Such large samples present unique challenges, however. For
instance, two recent studies, Berg et al. (on which I am a coauthor, see Appendix)
[33] and Sohail et al. [34], discovered that the signals of polygenic selection previously
detected for height have been inflated by population structure confounding in the
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GWAS (a spurious correlation between a genotype and a trait caused if the genotype
covaries with causal loci or with environmental factors contributing to the trait).
Previous polygenic selection analysis on height relied on the GWAS performed by the
GIANT consortium [35, 36]. However, polygenic adaptation signals were diminished
or largely attenuated when based on GWAS results from the UK Biobank, which
included individuals of relatively homogenous ancestry compared to GIANT which
was a meta-analysis of independent GWAS with samples from across Europe. Further
analyses pointed to biases in GIANT effect size estimates along the geographical
axis where signals of polygenic selection were previously detected. Without access to
individual-level data, it is difficult to assess the source of the problem in GIANT. One
possibility is that current state-of-the-art methods to deal with population structure
are not sufficient, especially when meta-analyzing results across different sources.
These findings further raise the more general question of the reliability of GWAS
results. Of course the answer depends on the application. Systematic biases in GWAS
would likely have major consequences for polygenic analyses, e.g., polygenic adapta-
tion as discussed above or any application that uses PGS [37, 38], which aggregate
subtle biases across many loci. In their simplest form, PGS are calculated as the
number of trait-increasing alleles carried by an individual weighted by their effect
size estimated in GWAS. In addition to evolutionary analyses, PGS are increasingly
being used in fields such as human genetics and social sciences. In human genetics
the goal is to identify individuals at risk of disease in the tail of the disease liability
PGS distribution (e.g., [39, 40, 41, 42]). In social sciences, PGS are used to control
for genetic variation in order to gain resolution on the effect of an environmental
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factor or policy (e.g., schooling reform) on an outcome (e.g., BMI) [43, 44, 45].
One major obstacle to the broad use of PGS is that PGS lose their predictive
ability (typically measured by how much of the trait variation they explain in a
sample not included in the GWAS) in samples that have different ancestry than the
GWAS sample [46, 47, 48]. In other words, PGS are not “portable” across ancestry
groups. For example, Martin et al. reported that averaged across a number of traits
in the UK Biobank, the prediction accuracy of PGS based on European ancestry
individuals (reflecting the state of the field that available GWAS are predominantly
performed in European ancestry individuals) drops by a factor of 2 in samples with
East Asian ancestry and by a factor of 5 in samples with African ancestry (relative
to European ancestry samples) [47].
Recent discussion about this challenge has focused primarily on the impact of
differences in linkage disequilibrium patterns and allele frequencies across human
populations that arose from their distinct demographic and recombination histories
[46, 49, 50, 51, 52, 53]. However, factors other than ancestry could in principle affect
PGS portability, e.g., indirect genetic effects (“genetic nurture”), assortative mating,
population structure confounding, gene-by-environment interaction (GxE) [54, 55,
56, 57, 58, 59, 60]. I discuss these factors in more detail in Chapter 2, and present
results illustrating that these considerations are not hypothetical [61].
To this end, we focused on a subset of the UK Biobank with relatively homogenous
ancestry [28]. With three example traits, diastolic blood pressure, BMI and years
of schooling, we show that within this homogenous group, the portability of PGS
depends on the characteristics of the GWAS and prediction sets, such as sex, age and
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socioeconomic status (SES). Such characteristics inevitably vary across data sets. We
compare PGS based on standard GWAS and PGS based on sibling-GWAS, i.e., by
detecting association by regressing phenotypic differences between siblings on their
genetic differences. In so doing, we demonstrate that processes such as parenting
behavior and assortative mating may have a large contribution to the predictive
power of PGS based on standard GWAS, notably for behavioral and social traits
such as years of schooling, smoking behavior and age at first sexual intercourse. As
these processes are socially and culturally mediated, it is likely that they vary between
as well as within ancestry groups. Taken together these results show that (i) PGS
prediction accuracy can vary within samples of similar genetic ancestry, and (ii) the
variable performance of PGS across ancestries cannot be predominantly attributed
to population genetic parameters.
In summary, the work presented in this thesis introduces two new types of studies
that are now possible with the advent of large genetic data sets, e.g., study of natural
selection in contemporary humans, and making phenotypic prediction using genetic
data, but also illustrates the new challenges involved with such opportunities, notably
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1.1 Abstract
A number of open questions in human evolutionary genetics would become tractable
if we were able to directly measure evolutionary fitness. As a step towards this
goal, we developed a method to examine whether individual genetic variants, or sets
of genetic variants, currently influence viability. The approach consists in testing
whether the frequency of an allele varies across ages, accounting for variation in
ancestry. We applied it to the Genetic Epidemiology Research on Adult Health and
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Aging (GERA) cohort and to the parents of participants in the UK Biobank. Across
the genome, we found only a few common variants with large effects on age-specific
mortality: tagging the APOE 4 allele and near CHRNA3. These results suggest that
when large, even late-onset effects are kept at low frequency by purifying selection.
Testing viability effects of sets of genetic variants that jointly influence 1 of 42 traits,
we detected a number of strong signals. In participants of the UK Biobank of British
ancestry, we found that variants that delay puberty timing are associated with a
longer parental life span (p  6:2  10 6 for fathers and p  2  10 3 for mothers),
consistent with epidemiological studies. Similarly, variants associated with later age
at first birth are associated with a longer maternal life span (p  1:4  10 3). Signals
are also observed for variants influencing cholesterol levels, risk of coronary artery
disease (CAD), body mass index, as well as risk of asthma. These signals exhibit
consistent effects in the GERA cohort and among participants of the UK Biobank of
non-British ancestry. We also found marked differences between males and females,
most notably at the CHRNA3 locus, and variants associated with risk of CAD and
cholesterol levels. Beyond our findings, the analysis serves as a proof of principle for
how upcoming biomedical data sets can be used to learn about selection effects in
contemporary humans.
1.2 Introduction
A number of central questions in evolutionary genetics remain open, in particular
for humans. Which types of variants affect fitness? Which components of fitness do
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they affect? What is the relative importance of directional and balancing selection
in shaping genetic variation? Part of the difficulty is that our understanding of
selection pressures acting on the human genome is based either on experiments in
fairly distantly related species or cell lines or on indirect statistical inferences from
patterns of genetic variation [4, 62, 63]. The statistical inferences rely on patterns
of genetic variation in present-day samples (or, very recently, in ancient samples
[64]) to identify regions of the genome that appear to carry the footprint of positive
selection [62]. For example, a commonly used class of methods asks whether rates
of nonsynonymous substitutions between humans and other species are higher than
expected from putatively neutral sites in order to detect recurrent changes to the
same protein [65]. Another class instead relies on polymorphism data and looks for
various footprints of adaptation involving single changes of large effect [66]. These
approaches detect adaptation over different timescales and, likely as a result, suggest
quite distinct pictures of human adaptation [4]. For example, approaches that are
sensitive to selective pressures acting over millions of years have identified individual
chemosensory and immune-related genes (e.g., [67]). In contrast, approaches that
are most sensitive to selective pressures active over thousands or tens of thousands
of years have revealed strong selective pressures on individual genes that influence
human pigmentation (e.g., [68, 69, 70]), diet [5, 71, 72], as well as sets of variants that
shape height [18, 21, 19]. Even more recent still, studies of contemporary populations
have suggested that natural selection has influenced life-history traits like age at first
childbirth as well as educational attainment over the course of the last century [73,
74, 75, 76, 30, 29, 31].
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Because these approaches are designed (either explicitly or implicitly) to be sensi-
tive to a particular mode of adaptation, they provide a partial and potentially biased
picture of what variants in the genome are under selection. In particular, most have
much higher power to adaptations that involve strongly beneficial alleles that were
rare in the population when first favored and will tend to miss selection on standing
variation or adaptation involving many loci with small beneficial effects (e.g., [77, 78,
79, 10]). Moreover, even where these methods identify a beneficial allele, they are
not informative about the components of fitness that are affected or about possible
fitness trade-offs between sexes or across ages. In line with Lewontin’s proposal to
track age-specific mortality and fertility of hundreds of thousands of individuals [80],
we sought a more direct and, in principle, comprehensive way to study adaptation in
humans, focusing on current viability selection. Similar to the approach that Allison
took in comparing frequencies of the sickle cell allele in newborns and adults living in
malarial environments [24], we aimed to directly observe the effects of genotypes on
survival by taking advantage of the recent availability of genotypes from large cohorts
of individuals of different ages. Specifically, we tested for differences in the frequency
of an allele across individuals of different ages, controlling for changes in ancestry
and possible batch effects. This approach resembles a genome-wide association study
(GWAS) for longevity yet does not focus on an end point (e.g., survival to an old age)
but on any shift in allele frequencies with age. Thus, it allows the identification of
possible nonmonotonic effects at different ages or sex differences. Any genetic variant
that affects survival by definition has a fitness cost, even if the cost is too small to
be effectively selected against (depending on the effective population size, the age
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structure of the population, and the age at which the variant exerts its effects [81]).
Of course, a genetic variant can influence fitness without influencing survival through
effects on reproduction or inclusive fitness. Our approach is therefore considering only
one of the components of fitness that are likely important for human adaptation.
As a proof of principle, we applied our approach to two recent data sets: to 57,696
individuals of European ancestry from the Genetic Epidemiology Research on Adult
Health and Aging (GERA) cohort [26, 27] and, by proxy [82, 83, 84], to the parents
of 117,648 individuals of British ancestry surveyed as part of the UK Biobank interim
data [85]. We did so for individual genetic variants then jointly for sets of variants
previously found to influence 1 of 42 polygenic traits [86, 87, 88, 89].
1.3 Results
1.3.1 A method for testing for differences in allele
frequencies across age bins
If a genetic variant does not influence viability, its frequency should be the same in
individuals of all ages. We therefore tested for changes in allele frequency across in-
dividuals of different ages, while accounting for systematic differences in the ancestry
of individuals of different ages (for example, due to migration patterns over decades)
and genotyping batch effects. We used a logistic regression model in which we re-
gressed each individual’s genotype on their age bin, their ancestry as determined by
principal component analysis (PCA) (Figure 1.6), and the batch in which they were
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genotyped (see Materials and Methods for details). In this model, we treated
age bin as a categorical variable; this approach allowed us to test for a relationship
between age and the frequency of an allele regardless of the functional form of this
relationship. We also tested a model with an interaction between age and sex to
assess whether a variant affects survival differently in the two sexes.
We first evaluated the power of this method using simulations. We considered 3
possible trends in allele frequency with age: (i) a constant frequency up to a given
age followed by a steady decrease, i.e., a variant that affects survival after a given age
(e.g., variants contributing to late-onset disorders), (ii) a steady decrease across all
ages for a variant with detrimental effect throughout life, and (iii) a U-shaped pattern
in which the allele frequency decreases to a given age but then increases, reflecting
trade-offs in the effects at young and old ages, as hypothesized by the antagonistic
pleiotropy theory of aging [90] or as may be seen if there are protective alleles that
buffer the effect of risk alleles late in life [91] (Figure 1.1). In all simulations, we used
sample sizes and age distributions that matched the GERA cohort (Figure 1.7). For
simplicity, we also assumed no population structure or batch effects across age bins
(see Materials and Methods). For all trends, we set a maximum of 20% change
in the allele frequency from the value in the first age bin (Figure 1.1).
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Figure 1.1: Power of the model to detect changes in allele frequency with age. (A)
Trends in allele frequency with age considered in simulations. The y-axis indicates the
allele frequency standardized to the frequency in the first age bin. (B) Power to detect the
trends in (A) at p < 5 10 8, given the sample size per age bin in the Genetic Epidemiology
Research on Adult Health and Aging (GERA) cohort (Figure 1.7 and total sample size of
57,696). Shown are results using models with age treated as a categorical (red) or an ordinal
(black) variable, assuming no change in population structure and batch effects across age
bins. The curves show simulation results sweeping allele frequency values with an increment
value of 0.001 (1,000 simulations for each allele frequency) smoothed using a Savitzky-Golay
filter in the SciPy package.
Because of the age distribution of individuals in the GERA cohort (Figure 1.7),
our power to detect the trend is greater when most of the change in allele frequency
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occurs in middle age (Figure 1.1). For example, for an allele with an initial allele
frequency of 0.15 that begins to decrease in frequency among individuals at age 20,
age 50, or age 70 years, there is around 20%, 90%, and 60% power, respectively,
to detect the trend at p < 5  10 8, the commonly used criterion for genome-wide
significance [92]. We also experimented with a version of the model in which the age
bin is treated as an ordinal variable; as expected, this model is more powerful if there
is in fact a linear relationship between age and allele frequency. Because we do not
know the functional form of the relationship between age and allele frequency a priori
in most cases, we used the categorical model for all analyses unless otherwise noted.
In the UK Biobank, all individuals were 45–69 years old at enrollment, so the age
range of the participants is restricted and our method has low power. However, the
UK Biobank participants reported the survival status of their parents: age of the
parents if alive or age at which their parents died; following recent studies [82, 83,
84], we therefore used these values (when reported) instead in our model. In this
situation, we are testing for correlations between an allele frequency and father’s or
mother’s age (if alive) or age at death (if deceased). This approach obviously comes
with the caveat that children inherit only half of their genome from each parent and
so power is reduced (e.g., [93]). Furthermore, the patterns expected when considering
individuals who have died differ subtly from those generated among surviving indi-
viduals. Notably, when an allele begins to decline in frequency starting at a given
age (Figure 1.1A), there should be an increase in the allele frequency among in-
dividuals who died at that age followed by a decline in frequency, rather than the
steady decrease expected among surviving individuals (Figure 1.8, see Materials
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and Methods for details). In a first analysis, we therefore focused on the majority
of participants who reported father’s or mother’s age at death, 88,595 and 71,783
individuals, respectively. We compared the results of this approach with the results
of a Cox proportional hazards model [94], which allowed us to include individuals
who reported their parents to be alive but has the disadvantage of assuming fixed
effects across all ages.
We further adapted this model to allow us to test for changes in frequency at sets
of genetic variants jointly. Many phenotypes of interest, from complex disease risk
to anthropomorphic and life-history traits such as age at menarche, are polygenic
[95, 96]. If a polygenic trait has an effect on fitness, either directly or indirectly
(i.e., through pleiotropic effects), the individual loci that influence the trait may be
too subtle in their survival effects to be detectable with current sample sizes. We
therefore investigated whether there is a shift across ages in sets of genetic variants
that were identified as influencing a trait in GWASs (Table 1.2). Specifically, for a
given trait, we calculated a polygenic score for each individual based on trait effect
sizes of single variants previously estimated in GWASs and then tested whether the
scores vary significantly across 5-year age bins (see Materials and Methods for
details). These scores are calculated under an additive model, which appears to
provide a good fit to GWAS data [97].
If a polygenic trait is under stabilizing selection (e.g., human birth weight [98]),
i.e., an intermediate polygenic score is optimal, no change in the mean value of
polygenic scores across different ages is expected. However, if extreme values of a
trait are associated with lower chance of survival, the spread of the polygenic scores
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should decrease with age. To consider this possibility, we tested whether the squared
difference of the polygenic scores from the mean varies significantly with age (see
Materials and Methods for details).
1.3.2 Testing for changes in allele frequency at individual
genetic variants
We first applied the method to the GERA cohort using 8,868,517 filtered genotyped
and imputed autosomal biallelic single-nucleotide polymorphisms (SNPs) and indels.
We focused on a subset of 57,696 filtered individuals who we confirmed to be of Eu-
ropean ancestry by PCA (see Materials and Methods, Figure 1.9 and Figure
1.10). The ages of these individuals were reported in bins of 5-year intervals (distri-
bution shown in Figure 1.7). We tested for significant changes in allele frequencies
across these bins. For each variant, we obtained a p-value comparing a model in which
the allele frequency changes with age to a null model. No inflation was detected in the
quantile-quantile plot (Figure 1.11A), indicating that, for common variants at least,
our control for population structure (and other potential confounders) is sufficient.
To illustrate this point, we looked at the lactose intolerance-linked SNP rs4988235
within the LCT locus, which is among the most differentiated variants across Eu-
ropean populations [5]; the trend in the expected allele frequency based on the null
model (i.e., accounting for confounding batch effects and changes in ancestry) tracks
the observed trend quite well (Figure 1.12).
By our approach, all variants that reached genome-wide significance (p < 5  10 8)
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reside on chromosome 19 near the APOE gene (Figure 1.2A and Figure 1.13).
This locus has previously been associated with longevity in multiple studies [99, 100].
The APOE 4 allele is known to increase the risk of late-onset Alzheimer disease (AD)
as well as of cardiovascular diseases [101, 102]. We observe a monotonic decrease in
the frequency of the T allele of the 4 tag SNP rs6857 (C, protective allele; T, risk
allele) beyond the age of 70 years old (Figure 1.2B). This trend is observed for both
the heterozygous and homozygous risk variants (Figure 1.14) and for both males
and females (Figure 1.15). No variant reached genome-wide significance testing for
age by sex interactions (quantile-quantile plot shown in Figure 1.11B).
We further investigated the trends in frequency with age for the other 2 major
APOE alleles defined by rs7412 and rs429358 SNPs: 2 (rs7412-T, rs429358-T) and 4
(rs7412-C, rs429358-T), while 4 is known by rs7412-C and rs429358-C alleles. Unlike
the 4 allele, 2 allele carriers are suggested to be at lower risk of AD, cardiovascular
disease, and mortality relative to the 3 carriers [99, 103]. We focused on a subset of
38,703 individuals with unambiguous counts of each APOE allele. There is a signif-
icant change in the frequency of the 4 allele with age in this subset (p  6  10 12),
similar to the trend observed for the tag SNP rs6857 (Figure 1.16). The 3 allele
shows the reverse trend, with a significant, monotonic increase in frequency beyond
the age of 70 years old (p  1:7 10 8) (Figure 1.16). The enrichment of the 3 allele
in elderly individuals can be explained by the corresponding depletion of the 4 allele
and does not necessarily imply an independent, protective effect of the 3 allele. The
frequency of the 2 allele does not change significantly with age (p  0:21), possibly
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reflecting low power given its allele frequency of approximately 0.06 (Figure 1.16).
Figure 1.2: Testing for the influence of single genetic variants on age-specific mortality
in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. (A)
Manhattan plot of p-values for the change in allele frequency with age. The red line marks
the p = 5  10 8 threshold. (B) Allele frequency trajectory of rs6857, a tag SNP for the
APOE 4 allele, with age. Data points are the frequencies of the risk allele within 5-year
interval age bins (  2 SE), with the center of the bin indicated on the x-axis (except for
the first and the last points). Bins with ages below 38 years are merged into 1 bin because
of the relatively small sample sizes. The dashed line shows the expected frequency based
on the null model, accounting for confounding batch effects and changes in ancestry (see
Materials and Methods). In orange are the mean ages at onset of Alzheimer disease for
carriers of 0, 1, or 2 copies of the APOE 4 allele [101].
We considered the possibility that some unobserved confounding variable was driving
the strength of this signal at APOE. Since there are 2 genotyped SNPs with signals
similar to rs6857 within the locus, genotyping error seems unlikely to be driving the
pattern (Figure 1.13). Another concern might be a form of ascertainment bias, in
which individuals with AD are underrepresented in the Kaiser Permanente Medical
Care Plan. However, there is no correlation in these data between the amount of time
that an individual has been enrolled in this plan and the individual’s APOE genotype
(Figure 1.17). These observations, along with previously reported associations at
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this locus, argue that the allele frequency trends in Figure 1.2B are driven by effects
of APOE genotype on mortality (or severe disability). Moreover, the effects that we
identified are concordant with epidemiological data on the mean age at onset of AD,
given 0 to 2 copies of APOE 4 allele [101]. This case not only serves as a positive
control for our approach, it illustrates the resolution that it provides about age effects
of genetic variants.
We estimated that we have about 93% power to detect the trend in allele frequency
with age as observed for rs6857 (at a genome-wide significance level, see Materials
and Methods). Using both versions of the model treating age bin as a categorical or
an ordinal variable, we have similar power to detect other potential trends considered
in Figure 1.1 for variants as common as rs6857 and with similar magnitude of effect
on survival. Yet across the genome, only APOE variants show a significant change
in allele frequency with age for both versions of the model (Figure 1.2 and Figure
1.18). Thus, our finding only APOE 4 allele indicates that there are few or no other
common variants in the genome with an effect on survival as strong as is seen in the
APOE region.
We then turned to the UK Biobank data set. We applied our method to individuals of
British ancestry whose data passed our filters; of these, 88,595 had death information
available for their father and 71,783 for their mother. We analyzed 590,437 genotyped
autosomal variants, applying similar quality control (QC) measures as with the GERA
data set (see Materials and Methods). We tested for significant changes in allele
frequencies with father’s age at death and mother’s age at death stratified in eight
5-year interval bins. As in the GERA data set, no inflation was detected in the
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quantile-quantile plots (Figure 1.19).
Consistent with recent studies [82, 83], the variants showing a genome-wide significant
change in allele frequency with father’s age at death (p < 5  10 8) reside within a
locus containing the nicotine receptor gene CHRNA3 (Figure 1.3A). The A allele
of the CHRNA3 SNP rs1051730 (G, major allele; A, minor allele) has been shown to
be associated with increased smoking quantity among individuals who smoke [104].
We observe a linear decrease in the frequency of the A allele of rs1051730 throughout
almost all age ranges (Figure 1.3B) p  1:3  10 7 and p  2:7  10 10, treating
paternal age at death as a categorical or an ordinal variable, respectively). Although
it does not reach genome-wide significance, this allele shows a similar trend with age
in GERA (p  8:6  10 3, Figure 1.20). We note that 30,819 of the UK Biobank
individuals included in the above analysis were genotyped on the UK BiLEVE Axiom
array (see Materials and Methods), selected based on lung function and smoking
behavior (while the remaining 57,776 samples were genotyped on the UK Biobank
Axiom array) [28]. Expectedly, the frequency of the A allele is significantly higher
among UK BiLEVE subjects (p  2:3  10 10), but the age effects are similar across
both arrays (p  0:72).
For mother’s age at death, a SNP in a locus containing the MEOX2 gene reached
genome-wide significance (Figure 1.3C). The C allele of rs4721453 (T, major allele;
C, minor allele) increases in frequency in the age bin centered at 76 years old (Figure
1.21), i.e., there is an enrichment among individuals who died at 74 to 78 years of
age, which corresponds to a deleterious effect of the C allele in this period. The trend
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Figure 1.3: Testing for the influence of single genetic variants on age-specific mortality in
the UK Biobank. (A) Manhattan plot of p-values, obtained from testing for a change in
allele frequency with age at death of fathers. (B) Allele frequency trajectory of rs1051730,
within CHRNA3 locus, with father’s age at death. (C) Manhattan plot of p-values, ob-
tained from testing for a change in allele frequency with age at death of mothers. (D) Allele
frequency trajectory of rs769449, within the APOE locus, with mother’s age at death. Red
lines in (A) and (C) mark the p = 5  10 8 threshold. Data points in (B) and (D) are the
frequencies of the risk allele within 5-year interval age bins ( 2 SE), with the center of the
bin indicated on the x-axis (except for the first and the last points). The dashed line shows
the expected frequency based on the null model, accounting for confounding batch effects
and changes in ancestry (see Materials and Methods).
is similar and nominally significant for other genotyped common SNPs in moderate
linkage disequilibrium with rs4721453 (Figure 1.21). Also, the signal for rs4721453
remains nominally significant when using subsets of individuals genotyped on the
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same genotyping array: 44,552 individuals on the UK Biobank Axiom array (p 
6:6  10 5) and 25,231 individuals on the UK BiLEVE Axiom array (p  1:1  10 4).
These observations suggest that the result is not due to genotyping errors, but it is not
reproduced in GERA (p  0:023, Figure 1.22) and so it remains to be replicated.
Variants within the APOE locus are among the top nominally significant variants
(Figure 1.3C). At the APOE SNP rs769449 (G, major allele; A, minor allele), there
is an increase in the frequency of A allele at around 70 years old before subsequent
decrease (Figure 1.3D, p  1:2 10 7). This pattern is consistent with our finding in
GERA (of a monotonic decrease beyond 70 years of age), considering the difference
in patterns expected between allele frequency trends with age among survivors versus
individuals who died (Figure 1.8).
We note that by considering parental age at death of the UK Biobank participants—as
done also in [82, 83, 84]—we introduce a bias towards older participants, who are more
likely to have deceased parents (Figure 1.23). We confirmed that our top signals
are not significantly affected after adjusting for age of the participants (among other
potential confounders, including participants’ sex, year of birth, and socioeconomic
status, as measured by the Townsend deprivation index): results remain similar for
the SNP rs4721453 near MEOX2 (p  1:210 9), APOE SNP rs769449 (p  1:510 6),
and CHRNA3 SNP rs1051730 (p  1:8 10 6 and p  4:3 10 9, treating paternal age
at death as a categorical or an ordinal variable, respectively).
We further tested for trends in allele frequency with parental age at death that differ
between fathers and mothers, focusing on 62,719 individuals with age at death infor-
mation for both parents. No variant reached genome-wide significance level (Figure
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1.24A). The rs4721453 near the MEOX2 gene and APOE variant rs769449 show
nominally significant sex effects (p  7:2  10 8 and p  2:2  10 3, respectively), with
stronger effects in females (Figure 1.24B). Variants near the CHRNA3 locus are
nominally significant when using the model with parental ages at death treated as
ordinal variables (rs11858836, p  5:7  10 4), with stronger effects in males (Figure
1.24B).
1.3.3 Testing for changes in allele frequency at
trait-associated variants
We next turned to sets of genetic variants that have been associated with polygenic
traits rather than individual genetic variants. We focused on 42 polygenic traits,
including disease risk and traits of evolutionary importance such as puberty timing,
for which a large number of common variants have been mapped in GWASs (seeTable
1.2 for the list of traits and number of loci) [86, 87, 88, 89]. For each individual
and each trait, we calculated a polygenic score based on the genetic variants that
reached genome-wide significance level for association and then tested whether this
polygenic score, or its squared difference from the mean in the case of stabilizing
selection, is associated with survival (after controlling for covariates, see Materials
and Methods).
We first applied the Cox proportional hazards model in the UK Biobank for parental
survival, focusing on the participants whose genetic ancestry is British and who re-
ported their father’s or mother’s age or age at death (114,122 and 116,323 individuals,
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respectively). We then compared the results with our approach of testing for changes
in the polygenic score across parental ages at death. We further analyzed 2 data
sets for replication purposes: participants of the UK Biobank of non-British ances-
try (29,511 and 30,372 individuals reporting father’s or mother’s age information,
respectively) and the GERA cohort.
Using the Cox model, the scores for several traits show significant associations with
father’s survival after accounting for multiple testing (Figure 1.4A, Table 1.1):
total cholesterol (TC, p  4:3  10 11), low-density lipoproteins (LDL, p  8:1  10 9),
body mass index (BMI, p  1:8  10 8), and coronary artery disease (CAD, p 
910 6), consistent with 2 recent studies [83, 84]. In addition, we uncovered significant
association between the polygenic score for puberty timing (p  6:2  10 6); in this
analysis, we used age at menarche-associated variants in females, motivated by the
high genetic correlation between the timing of puberty in males and females [105]). A
higher score for puberty timing is associated with longer paternal survival (per year
hazard ratio of 0.96) (Table 1.1), indicating that variants delaying puberty timing
are associated with a higher chance of survival, consistent with epidemiological studies
suggesting early puberty timing to be associated with adverse health outcomes [106].
For all other traits, a higher score is negatively associated with paternal survival:
1 standard deviation (SD) hazard ratio of 1.09 for TC, 1.08 for LDL, and 1.22 for
BMI (Table 1.1). With the exception of lipid traits, the effects on survival are not
significantly changed after accounting for the effect of the polygenic score of another
trait (Figure 1.25). This is especially relevant to BMI and puberty timing, for
which there is substantial genetic overlap [87]; the per year hazard ratio is 0.97 for
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the puberty timing score (p  4:8  10 4) after adjusting for the BMI score.
Using our approach instead, i.e., considering the father’s age at death, led to very
similar results. Specifically, all traits significantly associated with paternal survival
show a significant change in polygenic score with father’s age at death using the
model with parental ages at death treated as ordinal variables (Figure 1.26): TC
(p  8:8  10 9), CAD (p  3:3  10 8), puberty timing (p  1:6  10 7), LDL (p 
8:6  10 7), and BMI (p  3:4  10 6). In addition, we uncovered significant changes
in polygenic score with father’s age at death for asthma (ATH, p  9:4  10 5) and
triglycerides (TG, p  4:4 10 4, the effect of which does not seem to be distinct from
other lipid traits, Figure 1.25). The score for puberty timing increases monotonically
with the father’s age at death (Figure 1.4B), indicative of a protective effect of
later predicted puberty timing, whereas all other traits with significant signal show
a monotonic decline in score with age (Figures 1.4C-F).
In a Cox survival model, for mothers as with for fathers, scores for TC, CAD, and
LDL are significantly associated with survival, with similar hazard ratios (Figure
1.5A and Table 1.1): 1 SD hazard ratio of 1.09 for LDL (p  5:2  10 8), 1.09
for CAD (p  5:2  10 6), and 1.07 for TC (p  7:8  10 6). In addition, the high-
density lipoproteins (HDL) score is associated with maternal survival (1 SD hazard
ratio of 0.94, p  8:9  10 5). Also, suggestive evidence was detected for protective
effects of increased predicted age at first birth (AFB) (per year hazard ratio of 0.94,
p  1:3  10 3) as well as predicted puberty timing (per year hazard ratio of 0.97,
p  2 10 3) (Figure 1.5A and Table 1.1). Other than the LDL and TC, all signals
seem to be distinct (Figure 1.25), including for puberty timing and AFB, despite
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the genetic correlation between the 2 phenotypes [88].
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Figure 1.4: Testing for the influence of sets of trait-associated variants on survival of the
fathers of UK Biobank participants. (A) Quantile-quantile plot for association between the
polygenic score of 42 traits (see Table 1.2) with father’s survival, using the Cox model. The
red line indicates the distribution of the p-values under the null model. Signs “+” and “−”
indicate protective and detrimental effects associated with higher values of polygenic scores,
respectively. See Table 1.3 for values and hazard ratios for all traits. (B-F) Trajectory
of polygenic score with age at death of fathers for top traits associated with paternal
survival (only independent signals are shown, see Figure 1.25): puberty timing (using age
at menarche-associated variants) in males (B), total cholesterol (TC) (C), coronary artery
disease (CAD) (D), body mass index (BMI) (E), and asthma (ATH) (F). Data points in
(B-F) are mean polygenic scores within 5-year interval age bins ( 2 SE), with the center
of the bin indicated on the x-axis (except for the first and the last points). The dashed line
shows the expected score based on the null model, accounting for confounding batch effects,
changes in ancestry, and participant’s age, sex, year of birth, and the Townsend index (a
measure of socioeconomic status).
Table 1.1: Associations between sets of trait-associated variants and paternal and maternal
survival among the UK Biobank participants of British ancestry, under the Cox model.
Trait Scaling effect Father Mother
Effect size (SE) HR p-value Effect size (SE) HR p-value
Puberty timing 1 year -0.0363 (0.008) 0.96 6:2  10 6 -0.0278 (0.009) 0.97 0.002
AFB 1 year -0.0398 (0.018) 0.96 0.27 -0.0639 (0.02) 0.94 0.0014
ATH 1 unit log-odds 0.0279 (0.0109) 1.03 0.01 0.0149 (0.0121) 1.02 0.22
BMI 1 SD 0.1996 (0.0355) 1.22 1:8  10 8 0.0823 (0.0395) 1.08 0.037
CAD 1 unit log-odds 0.0784 (0.0177) 1.08 9  10 6 0.0892 (0.0196) 1.09 5:2  10 6
HDL 1 SD -0.0340 (0.0139) 0.97 0.014 -0.0605 (0.0154) 0.94 8:9  10 5
LDL 1 SD 0.0806 (0.014) 1.08 8:1  10 9 0.0844 (0.0155) 1.09 5:2  10 8
TC 1 SD 0.0901 (0.0137) 1.09 4:3  10 11 0.0679 (0.0152) 1.07 7:8  10 6
Abbreviations: AFB, age at first birth; ATH, asthma; BMI, body mass index; CAD, coronary artery index;
HR, hazard ratio; HDL, high-density lipoproteins; TC, total cholesterol
Applying our approach to maternal age at death instead, puberty timing and AFB are
the top signals (p  2:2  10 4 and p  3:1  10 3, respectively, Figure 1.26). Higher
polygenic scores for puberty timing are enriched among longer-lived mothers (Figure
1.5B), as seen for fathers. Similarly, the score for AFB increases with mother’s age at
death (Figure 1.5C), indicating an association between variants that delay AFB and
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longer life span. Scores for CAD, LDL, and HDL did not show significant monotonic
change across mother’s age at death bins (p  7:7  10 3, p  0:058, and p  0:35,
respectively); however, the trends are suggestive of subtle age-dependent effects, with
an effect of CAD score in middle age and late-onset effects of LDL and HDL scores
(Figures 1.5D-F). Testing for age by sex interactions, the TC and CAD score trends
with parental ages at death are significantly different between fathers and mothers
(p  4  10 4 and p  7:4  10 4, respectively, Figure 1.27).
To further investigate the age dependency of the effects, we plotted polygenic scores
among parents who had survived up to a given age as compared to the trends with
parental ages at death (Figure 1.28 and Figure 1.29). All traits associated with
paternal survival seemingly show more pronounced effects in middle age (Figure
1.28). Similar patterns were observed for maternal survival-associated traits except
for LDL and HDL, which had more pronounced late-age effects (Figure 1.29). We
also compared the hazard ratios for ages at death of  75 and > 75 years (Materials
and Methods), similar to a recent study [82]. Consistent with trends in scores with
parental age, among the traits associated with paternal survival, almost all traits
have seemingly stronger effects among younger fathers, particularly for CAD (Table
1.4): 1 SD hazard ratio of 1.14 for younger fathers (p  2:6  10 9) and 0.99 for
older fathers (p  0:7). Unlike in fathers, in mothers, TC, LDL, and HDL scores had
more pronounced late-age effects (Table 1.4): for TC, 1 SD hazard ratio of 1.03 for
younger mothers (p  0:15) and 1.11 for older mothers (p  1:4  10 6) and for LDL,
1 SD hazard ratio of 1.05 for younger mothers (p  0:03) and 1.12 for older mothers
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(p  3:3  10 8).
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Figure 1.5: Testing for the influence of sets of trait-associated variants on survival of the
mothers of UK Biobank participants. (A) Quantile-quantile plot for association between
the polygenic score of 42 traits (see Table 1.2) with mother’s survival, using the Cox model.
The red line indicates the distribution of the p-values under the null. Signs “+” and “−”
indicate protective and detrimental effects associated with higher values of polygenic scores,
respectively. See Table 1.3 for p-values and hazard ratios for all traits. (B-F) Trajectory of
polygenic score with age at death of mothers for top traits associated with maternal survival
(only independent signals are shown, see Figure 1.25): puberty timing (B), age at first
birth (AFB) (C), coronary artery disease (CAD) (D), low-density lipoproteins (LDL) (E),
and high-density lipoproteins (HDL) (F). Data points in (B-F) are mean polygenic scores
within 5-year interval age bins ( 2 SE), with the center of the bin indicated on the x-
axis (except for the first and the last points). The dashed line shows the expected score
based on the null model, accounting for confounding batch effects, changes in ancestry, and
participant’s age, sex, year of birth, and the Townsend index (a measure of socioeconomic
status).
Next, we sought to replicate the top associations observed among the UK Biobank
participants of British ancestry (discovery cohort) in 2 other data sets: participants
of the UK Biobank of non-British ancestry and the GERA cohort. Applying the Cox
model using parental survival for UK Biobank participants of non-British ancestry,
the direction of hazard ratios for all traits (as well as the estimated values for most
traits) are consistent with the discovery cohort for both fathers and mothers (Table
1.5). The congruence of results in 2 cohorts with different ancestries suggests that
our top signals are not false positives caused by poor control for population structure.
In the GERA cohort, we tested whether polygenic scores change with the age of the
participant, similar to our approach for individual genetic variants in this cohort.
All top signals except AFB have directionally consistent effects with the discovery
cohort (Table 1.6). Of particular interest, the strongest signal is an increase in the
polygenic score for puberty timing with age of the participants (p  6:710 3, Figure
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1.30).
In the discovery cohort, we further investigated if there are significant changes in
the squared difference of polygenic scores with parental ages at death, as might be
expected if the mean value of the trait leads to the highest chance of survival. No
trait shows evidence of such stabilizing selection (Figure 1.31).
1.4 Discussion
We introduced a new approach to identify genetic variants that affect survival to a
given age and thus to directly observe viability selection ongoing in humans. At-
tractive features of the approach include that we do not need to make a decision a
priori about which loci or traits matter to viability and focus not on an end point
(e.g., survival to an old age) but on any shift in allele frequencies with age, thereby
learning about the ages at which effects are manifest and possible differences between
sexes.
To illustrate the potential of our approach, we performed a scan for genetic variants
that impact age-specific mortality in the GERA and the UK Biobank cohorts. We
only found a few individual genetic variants, almost all of which were identified in
previous studies. This result is in some ways expected: available data only provide
high power to detect effects of common variants (> 0:15–0:2) on survival (Figure
1.1), yet if these variants were under viability selection, we would not expect them to
be common, short of strong balancing selection due to trade-offs between sexes, ages,
or environments. As sample sizes increase, however, the approach introduced here
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should provide a comprehensive picture of viability selection in humans. To illustrate
this point, we repeated our power simulation with 500,000 samples and found that we
should have high power to detect the trends for alleles at a couple percent frequency
in the sample (Figure 1.32).
Already, however, this application raises a number of interesting questions about the
nature of viability selection in humans. Notably, we discovered only a few individual
variants influencing viability in the 2 cohorts, most of which exert their effect late in
life. On first thought, this finding may suggest such variants to be neutrally evolving.
We would argue that if anything, our findings of only a few common variants with
large effects on survival late in life suggest the opposite: that even variants with late-
onset effects have been weeded out by purifying selection. Indeed, unless the number
of loci in the genome that could give rise to such variants (i.e., the mutational target
size) is tiny, other variants such as the APOE 4 allele must often arise. That they are
not observed when we have very high power to detect them suggests they are kept at
lower frequency by purifying selection. Why might they be selected despite affecting
survival only at old ages? Possible explanations include that they decrease the direct
fitness of males sufficiently to be effectively selected (notably given the large, recent
effective population size of humans [107]) or that they impact the inclusive fitness of
males or females. If this explanation is correct, it raises the question of why the APOE
4 allele has not been weeded out. We speculate that the environment has changed
recently, making this allele more deleterious. For example, it has been proposed that
the evolution of this allele has been influenced by changes in physical activity [108]
and parasite burden [109].
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Considering 42 traits that have been investigated by GWASs, we found a number of
cases in which the mean polygenic score changes with age. Of course, detecting an
effect of age on the traits does not imply that these are the phenotypes under viability
selection, as the variants that contribute likely have pleiotropic effects on other traits
[86]. Nonetheless, it is perhaps not surprising that we found detrimental effects of
higher genetically predicted TC, LDL, BMI, and risk of CAD on survival, as these
phenotypes are studied in GWASs precisely because of their adverse health effects.
Intriguingly, however, we also found associations for fertility traits, notably, protective
effects of later predicted puberty timing and AFB. If these findings reflect life-history
trade-offs (e.g., longer life span at the cost of delayed reproduction), they may help
to explain the persistence of extensive variation in such fitness-correlated traits [110,
111]. Intriguingly, we see a negative correlation between genetically predicted AFB
and number of siblings of the UK Biobank participants, a proxy for the fertility
of their parents (p  4:2  10 8, Figure 1.33), consistent with previous reports of a
genetic correlation between AFB and the number of children ever born [30, 88]. These
findings underscore that consideration of survival or fertility effects alone does not
allow one to infer whether the net effect of a variant or set of variants is beneficial.
Instead, to convert effects on viability such as those detected here, or effects on
fertility reported elsewhere [29, 31], into an understanding of how natural selection
acts on an allele requires a characterization of its effects on all components of fitness
(including potentially inclusive fitness).
In this regard, it is also worth noting that while our method is designed to detect
changes in allele frequencies (and in polygenic scores) caused by genetic effects on
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age-specific mortality, such changes could in principle also arise from effects on other
components of fitness. For example, if the frequency of a genetic variant in a popula-
tion decreases over decades due to an effect on fertility, its frequency would increase
with the age of surviving individuals sampled at a given time (as in the GERA co-
hort). This confounding is less of an issue when considering effects on the age at death
(what we measured in the UK Biobank). Nonetheless, even in the UK Biobank, fer-
tility effects may manifest as effects on age at death; for example, when sampling a
cohort of children, parents with later ages at death are possibly born earlier (Figure
1.34). To this end, in the UK Biobank, we accounted for changes in allele frequencies
with year of birth of the participants themselves (ideally, we would want to condition
on parents born at similar times, which we cannot do; instead, we used year of birth
of the participants as an estimator for year of birth of the parents). Thus, we believe
our results in the UK Biobank not to be confounded by fertility effects. Moreover, a
number of our findings in this study are consistent with prior knowledge of effects on
survival, such as those for disease risk variants like the APOE 4 allele. Nonetheless,
some caution is required in interpreting trends with age as strictly reflecting viability
effects.
Also of interest are the marked differences between males and females in our analysis
of mothers and fathers of individuals in the UK Biobank. The differences between
sexes are most notable at the CHRNA3 locus, which shows a strong effect only in
fathers, and sets of genetic variants associated with risk of CAD and cholesterol
levels, which exhibit different age-dependent effects between fathers and mothers.
Results for the CHRNA3 locus, in which variants are associated with the amount of
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smoking among smokers, may reflect a gene-by-environment interaction rather than
a sex effect per se. Consistent with a more pronounced effect on male than female age
at death, smoking prevalence in men has been consistently higher than women over
the past few decades in the United Kingdom: from 1970 to 2000, smoking prevalence
decreased from around 70% to 36% in middle-aged men, compared to from around
50% to 28% in middle-aged women [112].
Moving forward, the application of approaches such as ours to the millions of samples
in the pipeline (such as the UK Biobank [113], the Precision Medicine Initiative
program [114], and the BioVU biobank at Vanderbilt University [115]) will allow
viability effects of rare as well as common alleles to be examined. These analyses will
provide a comprehensive answer to the question of which loci affect survival, helping
to address long-standing open questions such as the relative importance of viability
selection in shaping genetic variation and the extent to which genetic variation is
maintained by fitness trade-offs between sexes or across ages.
1.5 Materials and Methods
Data sets.
GERA cohort. We performed our analyses on the data for 62,318 participants
of the GERA cohort (who are members of the Kaiser Permanente Medical Care Plan,
Northern California Region and participating in its Research Program on Genes,
Environment, and Health), self-reported to be “White-European American”, “South
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Asian”, “Middle-Eastern”, or “Ashkenazi” but no other ethnicities among a list of
23 choices on the GERA survey, and genotyped on a custom array at 670,176 SNPs
designed for Non-Hispanic white individuals [26, 27]. We considered the age of the
participants and the number of years they were enrolled in the Kaiser Permanente
Medical Care Plan at the time of the survey (year 2007).
UK Biobank. We performed our analyses on the data for 152,729 participants
of the UK Biobank study, focusing on 120,286 individuals identified to be “British”
by genetic analysis, and all other individuals for replication. They were genotyped on
the UK Biobank Axiom or the UK BiLEVE Axiom SNP arrays at a total of 847,441
SNPs in the interim release [85].
QC.
GERA cohort. We used PLINK v1.9 [116] to remove individuals with missing
sex information or with a mismatch between genotype data and sex information,
individuals with <96% call rate, and related individuals. We validated self-reported
European ancestries using PCA, see below, and removed individuals identified as non-
European (Figure 1.9 and Figure 1.10). In the end, 57,696 individuals remained.
Using PLINK, we removed SNPs with < 1% minor allele frequency, SNPs with < 95%
call rate, and SNPs failing a Hardy-Weinberg equilibrium test with p < 10 8 (filtering
based on HWE test could potentially exclude true signals of viability selection if
selection coefficients were very large [117], but this possibility is much less likely
than genotyping error). We additionally tested for a correlation between age (or
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sex) and proportion of missing data, which can induce artificial change in the allele
frequencies as a function of age (or sex). We thus removed SNPs showing a significant
age-missingness or sex-missingness correlation, defined as a chi-squared test with
p < 10 7. After these steps, 583,357 SNPs remained.
We imputed the genotypes of the filtered GERA individuals using post-QC SNPs and
using the 1000 Genomes phase 3 haplotypes as a reference panel [118]. We phased
observed genotypes using EAGLE v1.0 software [119]. The inferred haplotypes were
then passed to IMPUTE2 v2.3.2 software for imputation in chunks of 1 Mb using the
default parameters of the software [120]. To gain computational speed, variants with
minor allele frequency of <0.005 in the 1000 Genomes European populations were
removed from the reference panel. This step should not affect our analysis because
our statistical model is not well powered for rare variants, given the GERA data
sample size. We called imputed genotypes with posterior probability of > 0:9 and
then filtered the imputed genotypes, removing variants with IMPUTE2 info score of
< 0:5 and with minor allele frequency of <0.01. We also used imputation with a leave-
one-out approach [121] to impose a second stage of QC on genotyped SNPs, removing
SNPs that were imputed back with high reported certainty (info score > 0:5) and
with < 90% concordance between the imputed and the original genotypes. These
yielded a total of 8,868,517 imputed and genotyped biallelic SNPs and indels.
For our analysis of the APOE alleles (2, 3, and 4), which are defined by rs7412
and rs429358 SNPs [103], given the lack of tag SNPs for all 3 alleles, we kept a subset
of 38,703 individuals with no poorly imputed genotypes for these 2 SNPs, for whom
the count of each APOE allele could be determined unambiguously.
39
UK Biobank. In the UK Biobank, we obtained sets of genotype calls and the
output of imputation as performed by the UK Biobank researchers [85]. We first
applied QC metrics to the autosomal genotyped SNPs, focusing on the individuals of
British genetic ancestry. We used PLINK to remove SNPs with minor allele frequency
of < 0:01, SNPs with < 95% call rate, and SNPs failing a Hardy-Weinberg equilibrium
test with p < 10 8. These filters were applied separately to SNPs genotyped on
the UK Biobank Axiom and the UK BiLEVE Axiom arrays. Then, we divided the
genotyped SNPs into 3 sets (SNPs specific to either array and shared SNPs) and then
performed additional QC on each set separately: we removed SNPs with significant
allele frequency difference between genotyped and imputed calls (chi-squared test
p < 10 5) and SNPs showing a significant correlation between proportion of missing
data and age or sex of the participants as well as with participants’ father’s or mother’s
age at death (chi-squared test p < 10 7). We then extracted this list of SNPs from the
imputed genotype files available from the UK Biobank (we did not use the full set of
imputed genotypes). From this set, we removed SNPs with minor allele frequency of
< 0:01, SNPs with < 95% call rate, and SNPs failing a Hardy-Weinberg equilibrium
test with p < 10 8, yielding 590,437 SNPs. For variants influencing quantitative
traits, we first extracted them from imputed genotype files and then imposed similar
QC measures as above. For individuals of non-British ancestry, we first extracted the
trait-influencing variants from imputed genotype files and then removed SNPs with
minor allele frequency of < 0:01 and SNPs with < 90% call rate.
Each participant was asked to provide the survival status and age of their father and
their mother on each assessment visit. For each participant who reported an age at
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death of father and/or mother, we averaged over the ages reported at recruitment and
any subsequent repeat assessment visits and used PLINK to exclude individuals with
> 5-year variation in their answers across visits (around 800 individuals). For those
reporting their parents to be alive, the latest assessment visit was considered. We also
removed adopted individuals, individuals with a mismatch between genotype data and
sex information, and individuals with missing values for the covariates, resulting in
88,595 individuals of British ancestry with age at death information for their father,
71,783 individuals of British ancestry with age at death information for their mother,
and 62,719 individuals of British ancestry with age at death information for both
parents. For the survival analyses, we further removed individuals with evidently
invalid parental survival status, particularly parental ages at death values smaller
than their age when still alive, resulting in 114,122 and 116,323 individuals of British
ancestry with paternal and maternal survival information, respectively. With similar
QC measures, 29,511 and 30,372 individuals of non-British ancestry with paternal
and maternal survival information, respectively, were analyzed.
PCA.
We performed PCA using the EIGENSOFT v6.0.1 package with the fastpca algorithm
[122, 123] for 2 purposes: (i) as a QC on individuals to validate self-reported European
ancestries (only in GERA data set) and (ii) to correct for population structure in our
statistical model (for individuals in the UK Biobank of non-British ancestry, we used
the PCs provided with the data).
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European ancestry validation. We used more stringent QC criteria specifi-
cally for the PCA compared to the QC steps described above. We filtered a subset
of 157,277 SNPs in GERA, retaining SNPs shared between the data sets and the
1000 Genomes phase 3 data, removing nonautosomal SNPs, SNPs with minor allele
frequency of < 0:01, SNPs with < 99% call rate, and SNPs failing a Hardy-Weinberg
equilibrium test with p < 10 6. We then performed LD pruning using PLINK with
pairwise r2 < 0:2 in windows of 50 SNPs shifting every 10 SNPs. We used these SNPs
to infer principal components for the 1000 Genomes phase 3 data [118]. We then pro-
jected individuals onto these PCs. We observed that the majority of individuals have
European ancestry and marked individuals with PCs deviating from the population
mean for any of the first 6 PCs as non-European (Figure 1.9 and Figure 1.10).
Control for population structure. After the main QC stage, additional QC
steps (as in European ancestry validation) were implemented for PCA. In the UK
Biobank, we also removed inversion variants on chromosome 8, which otherwise dom-
inate the PC2 (not shown). A subset of 156,721 SNPs in GERA and 207,657 SNPs
in the UK Biobank was then used to infer PCs for individuals passing QC (Figure
1.6). The first 10 PCs were used as covariates in our statistical model.
Quantitative traits.
We downloaded the list of variants contributing to 39 traits (all traits but age
at menarche, AFB, and age at natural menopause) and their effect sizes re-
cently described in Pickrell et al. [86] from: https://github.com/PickrellLab/
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gwas-pw-paper/tree/master/all_single. For age at menarche, we used the vari-
ants and effect sizes recently identified by Day et al. [87]. We used variants associated
with AFB from Barban et al. identified in either sex-specific analyses or analyses of
both sexes and used the effect sizes estimated in the combined analysis [88]. We used
age at natural menopause-associated variants and their effect sizes from Day et al.
[89]. For all traits, we used variants that were genotyped/imputed with high quality
in our data (see Table 1.2).
Statistical model.
An individual variant. Using a logistic regression, we predict the genotype
of individual j (the counts of an arbitrarily selected reference allele, Gij = 0; 1; or
2) at variant i, using the individual’s ancestry, the batch in which the individual
was genotyped, and the individual’s age (as well as sex, see below) as explanatory
variables. Specifically, the distribution of Gij is Bin(2; pij), where pij, the probability














where i is the effect of principal component l (to account for population structure),
m is the effect of being in batch m (to account for potential systematic differences
between genotyping packages), n is the effect of being in age bin n, obtained by
regression across individuals with nonmissing genotypes at variant i, and I and J
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are indicator variables for the genotyping batch and age bin, respectively. In the
version of the model in which we treat age as an ordinal variable, we replace J age
bin variables with 1 age variable. In the GERA data set, age binning is over the age
of the participants in 14 categories, from age 19 onwards, in 5-year intervals. For
replication purposes, we further binned the ages in 7 categories, in 10-year intervals,
to boost our power by increasing the sample size per bin, particularly for younger
age bins. In the UK Biobank, we binned the age at death of father or mother over 8
categories, from age 63 onwards, in 5-year intervals. In the UK Biobank, we included
all ages at death below 63 in one age bin to minimize the potential noise caused by
accidental deaths at young ages.
We tested for an effect of age categories by a likelihood ratio test with a null model
using only the covariates (PCs and batch terms) (H0 : n = 0, for all n) and an


















To test for age by sex effects in GERA, we included 2 sets of additional predictors. The
first consists in 2 indicator variables for sex, Kmale and Kfemale, which are included to
capture possible sex effects induced by potential genotyping errors or mismapping of
sex chromosome-linked alleles (we note that because of Hardy-Weinberg equilibrium,
mean allele frequency difference between males and females is not expected). The
second set of predictors consists in age by sex terms, J  K. We then compare a
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model with age and sex terms as predictors to a model also including age by sex
terms. To test for sex effects in the UK Biobank, we compared a model with both
father and mother age terms separately as predictors to a model with 1 set of age
categories for average age at death of both parents, only for individuals reporting the
age at death for both parents. In all models, PCs and batch terms were incorporated
as covariates. For the top SNPs in the UK Biobank, we additionally tested models
also including as covariates the participants’ age, sex, year of birth, and the Townsend
index (a measure of socioeconomic status). For rs1051730, we also tested whether
allele frequencies or trends in allele frequencies with the father’s age at death vary
significantly across the UK Biobank genotyping arrays after adjusting for population
structures, using similar models as described above.
Set of variants. As for the model described above for an individual variant, we
investigated age and age by sex effects on quantitative traits for which a large number
of common genetic variants have been identified in GWASs. For a given trait, we used
a linear regression with the same covariates and predictors as for the model for an
individual variant to predict the polygenic score for individual j, Sj (estimated by
summing the previously estimated effects of single variants, assuming additivity and
that the effect sizes are similar in the GWAS panels and the cohorts considered here):















2aiqi (standardized to mean 0), where the first sum
is across variants with nonmissing genotypes, ai is the effect size for the arbitrary
selected reference allele at variant i, and the second sum is across the variants with
missing genotypes estimating their contribution assuming Hardy-Weinberg equilib-
rium where qi is the frequency of the alternate allele. Likelihood ratio tests, as
described above, were used to test for age and age by sex effects. In the UK Biobank,
we additionally adjusted for participants’ age, sex, year of birth, and the Townsend
index.
To evaluate the possibility of stabilizing selection on a trait, we applied the same
model, but instead of the polygenic score, we regressed the squared difference of the
score from the mean in each bin, (Sj   SBIN;j)2, on the predictors, where SBIN;j is
the mean score in the age bin to which individual belongs.
We also used the Cox proportional hazards model [94] to evaluate the association
between polygenic scores and parental survival in the UK Biobank. Compared to
the model described above, this approach presents the advantage of allowing data
from participants with alive parents to be incorporated but has the disadvantage of
assuming fixed effects across all ages. Under this model, at a given time t (age in our
application):







where  is the hazard rate (probability of death within t+ dt conditional on survival
to time t) given the covariates, and 0 is the baseline hazard rate that describes
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the risk for individuals with the value of 0 for all predictors. Not shown in the
equation above are covariates to adjust for participants’ age, sex, year of birth, and
the Townsend index. Using the R package “Survival” [124], for a given trait, we
tested for a significant effect of polygenic score ( 6= 0). In addition, to assess
the interdependence of detected effects (Figure 1.25), for each pair of traits [a; b],
we tested for the effect of the polygenic score for trait a but also incorporated the
polygenic score for trait b as a covariate in the null model (in addition to the covariates
mentioned above).
We further investigated the age dependency of the effects in the framework of the
survival analysis by comparing hazard ratios in 2 age categories: ages at death of
 75 and > 75 years. For the category of ages at death  75 years, all parental ages
were included in the analysis, and parents with ages at death beyond 75 years were
marked as alive. For the category of ages at death > 75 years, only parents who
survived beyond 75 years were considered.
All Manhattan and quantile-quantile plots were generated using qqman [125] and
GWASTools [126] packages.
Power simulations.
We ran simulations to determine the power of our statistical model to detect deviation
of allele frequency trends with age across 14 age categories mimicking the GERA
cohort’s age structure (57,696 individuals with age distribution as in Figure 1.7)
from a null model, which for simplicity was no change in frequency with age, i.e.,
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no changes as a result of age-dependent variation in population structure and batch
effects. For a given trend in frequency of an allele with age, we generated 1,000
simulated trends in which the distribution of the number of the alleles in age bin i
is Bin(2Ni; fi), where Ni and fi are the sample size and the sample allele frequency
in bin i. We then estimated the power to detect the trend as the fraction of cases in
which p < 5  10 8, by a chi-squared test.
Survival simulations.
We ran simulations to investigate the relationship between allele frequency with age
of the surviving individuals and the age of the individuals who died in a cohort. We
simulated 2  106 individuals going forward in time in 1-year increments. For each
time step forward, we tuned the chance of survival of the individuals based on their
count of a risk allele for a given variant such that the number of individuals dying in
the increment complies with: (i) a normal distribution of ages at death with mean of
70 years and standard deviation of 13 years, roughly, as is observed for parental ages
at death in the UK Biobank and (ii) a given frequency of the risk allele among those
who survive. Specifically, we modeled the survival rate of the population, S, as the





where f denotes the frequency of genotypes in the population and x denotes the age.
Si and S are related: Si(x) = S(x)fi(x)/fi, where fi(x) is the genotype frequency
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among individuals survived up to age x. Given a trend in allele frequency with age,
we calculated genotype frequencies with age assuming Hardy-Weinberg equilibrium
and then estimated genotype-dependent chance of survival, Si(x), taking S(x) as the
survival function for N(70; 132).
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Figure 1.6: Results of principal component analysis (PCA). (A) PCA on 57,696 GERA in-
dividuals after quality control removing “non-European” individuals. (B) PCA on 120,286
UK Biobank participants of British ancestry. Result are in agreement with recent studies
of these data [123, 127].
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Figure 1.7: Age distribution of the GERA individuals at the time of the survey, year 2007.
The labels on the x-axis indicate the center of 5-year interval age bins (except the last
category).
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Figure 1.8: Comparison of trends in allele frequency with age and age at death. (A)
Simulated allele frequencies among surviving individuals, reproducing trends as in Figure
1.1A. (B) Trends in allele frequency among individuals who died, corresponding to the
trends in (A). Points are allele frequency within 5-year interval age bins (mean  2 SE).
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Figure 1.9: Validation of European ancestry in GERA. Shown are PCs inferred for all 26
populations in the 1000 Genomes Project phase 3 data. For clarity, in each plot, only a few
representative populations are shown. GERA individuals (blue dots) are projected on the
inferred PCs. The dashed lines correspond to the dashed lines in Figure 1.10, delimiting
the majority of GERA individuals.
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Figure 1.10: Distribution of GERA individuals for PCs inferred from 1000 Genome Project
phase 3 data. The dashed lines enclose the majority of the data points; beyond, individuals
were labeled as “non-Europeans”.
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Figure 1.11: Quantile-quantile plots for model results for individual variants in GERA.
Quantile-quantile plots for age (A) and age by sex (B) effects. The red lines indicate the
distribution of the p-values under the null model (of no age or age by sex effect) and the
shaded bands represent the 95% confidence intervals, assuming independent SNPs.
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Figure 1.12: Frequency of the G allele of rs4988235 with age of the GERA participants. The
data points are the frequencies within 5-year interval age bins ( 2 SE). The x-axis indicates
the center of the age bin (except for the first and the last bins). Bins with ages below 38
years are merged into 1 bin because of the relatively small sample sizes. The dashed line
shows the expected frequency based on the null model, accounting for confounding batch
effects and, importantly, changes in ancestry.
56
Figure 1.13: Regional plot for the APOE locus. The y-axis shows p-values obtained from
a test of the influence of single genetic variants on age-specific mortality in GERA.
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Figure 1.14: Frequency of rs6857 genotypes with age in GERA. Frequency of noncarriers
(A), heterozygous (B), and homozygous (C) carriers of the risk allele for rs6857, tagging
the 4 allele of the APOE gene, across GERA age bins. Data points are frequencies within
5-year interval age bins ( 2 SE), with the center of the bin indicated on the x-axis (except
for the first and the last bins). Bins with ages below 38 years are merged into 1 bin because
of the relatively small sample sizes per bin. The dashed line shows the expected frequency
based on the null model, accounting for confounding batch effects and changes in ancestry.
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Figure 1.15: Frequency of rs6857 genotypes with age among males and females in GERA.
Frequency of noncarriers (A), heterozygous (B), and homozygous (C) carriers of the risk
allele for rs6857, tagging the 4 allele of the APOE gene, across GERA age bins. Data
points are frequencies within 5-year interval age bins ( 2 SE), with the center of the bin
indicated on the x-axis (except for the first and the last bins). Bins with ages below 38 years
are merged into 1 bin because of the relatively small sample sizes per bin. The dashed line
shows the expected frequency based on the null model, accounting for confounding batch
effects and changes in ancestry.
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Figure 1.16: Frequency of the APOE gene alleles with age in GERA. Frequency of the 2
(A), 3 (B), and 4 (C) alleles across GERA age bins. Data points are frequencies within
5-year interval age bins ( 2 SE), with the center of the bin indicated on the x-axis (except
for the first and the last bins). Bins with ages below 38 years are merged into 1 bin because
of the relatively small sample sizes per bin. The dashed line shows the expected frequency
based on the null model, accounting for confounding batch effects and changes in ancestry.
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Figure 1.17: Enrollments of individuals in the Kaiser Permanente Medical Care Plan. (A)
Years enrolled in the care plan at the time of the survey (mean  SD) per age bin. The
x-axis indicates the center of 5-year interval age bins. (B) Years enrolled in the plan (mean
 SD) for individuals > 70 years old versus the rs6857 (APOE) genotype that they carry.
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Figure 1.18: Testing for the influence of single genetic variants on age-specific mortality in
the GERA cohort. Manhattan plot of p-values testing for a change in allele frequency with
age using the version of the model with age treated as an ordinal variable. The plot only
includes the filtered genotyped SNPs in the GERA study. Red line marks the p = 5  10 8
threshold. The signal for variant on chromosome 18 is presumably caused by genotyping
error, as other closely linked variants did not show a similar behavior, and the signal was
lost when the variant was imputed using a leave-one-out approach.
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Figure 1.19: Quantile-quantile plots for model results for individual variants in the UK
Biobank. Quantile-quantile plots for significant change in allele frequency with father’s (A)
and mother’s (B) age at death. The red lines indicate distribution of the p-values under the
null (no change in frequency) and the shaded bands represent the 95% confidence intervals,
assuming independent SNPs.
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Figure 1.20: Effect of rs1051730 (CHRNA3) on survival in GERA (p  8:6  10 3). Al-
lele frequency trajectory of rs1051730 with age for males and females together (A) and
separately (B). The data points are the frequencies within 10-year interval age bins ( 2
SE). The x-axis indicates the center of the age bin (except for the first and the last bins).
The dashed line shows the expected frequency based on the null model, accounting for
confounding batch effects and changes in ancestry.
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Figure 1.21: Allele frequencies of variants in the MEOX2 locus with mother’s age at death
in the UK Biobank. Plots are for 4 genotyped SNPs in moderate linkage disequilibrium
with p < 10 4 for the change in allele frequency with mother’s age at death. Data points
are frequencies within 5-year interval age bins ( 2 SE), with the center of the bin indicated
on the x-axis (except for the first and the last bins). The dashed line shows the expected
frequency based on the null model, accounting for confounding batch effects and changes
in ancestry.
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Figure 1.22: No significant effect of rs4721453 (near MEOX2) on survival in GERA (p 
0:023). Allele frequency trajectory of rs4721453 with age for males and females together
(A) and separately (B). The data points are the frequencies within 10-year interval age
bins ( 2 SE). The x-axis indicates the center of the age bin (except for the first and the last
bins). The dashed line shows the expected frequency based on the null model, accounting
for confounding batch effects and changes in ancestry.
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Figure 1.23: Ascertainment bias towards older participants introduced by using parental
ages at death in the UK Biobank. Fraction of the participants in each age bin (bin size of
3 years) who reported their father’s or mother’s age at death.
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Figure 1.24: Testing for a significant age by sex effect of individual genetic variants in
the UK Biobank. (A) Manhattan plot of p-values, testing a difference between fathers and
mothers in the change in allele frequency with parental age at death. (B) Allele frequencies
as a function of father’s and mother’s age at death for top SNPs with age effects: rs4721453
(near MEOX2), rs11858836 (near CHRNA3), and rs769449 (APOE). The data points are
the frequencies within 5-year interval age bins ( 2 SE). The x-axis indicates the center of
the age bin (except for the first and the last bins). The dashed line shows the expected
frequency based on the null model, accounting for confounding batch effects and changes
in ancestry.
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Figure 1.25: Heat map showing interdependence between the age effects of pairs of trait-
associated variants in the UK Biobank. Each square [i; j] shows the effect size (log[hazard
ratio]) of the polygenic score for trait i on father’s (left) or mother’s (right) survival in the
Cox model, after accounting for the effect of the polygenic score of trait j (i.e., incorpo-
rating the polygenic score for trait j as a covariate in the null model, see Materials and
Methods). Squares on the diagonal (marked by black rectangles) show the effect size of
the polygenic score without accounting for the score for other traits.
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Figure 1.26: Testing for age effect of sets of trait-associated variants in the UK Biobank,
treating age variables as ordinal. Quantile-quantile plots for changes in polygenic score of
42 traits (see Table 1.2) with father’s (A) or mother’s (B) age at death, after accounting
for confounding batch effects, changes in ancestry, and the participant’s age, sex, year of
birth, and the Townsend index (a measure of socioeconomic status). The red lines indicate
the distribution of the p-values under the null model. Signs “+” and “−” indicate protective
and deleterious effects associated with higher values of polygenic scores, respectively.
70
Figure 1.27: Testing for age by sex effect of sets of trait-associated variants in the UK
Biobank. (A) Quantile-quantile plot for changes in polygenic score of 42 traits (see Table
1.2) with parental ages at death that are different between fathers and mothers of the UK
Biobank participants. The red lines indicate the distribution of the p-values under the
null. (B) The trend in polygenic score with parental ages at death for total cholesterol and
coronary artery disease, which show significant age by sex effects. The data points are the
mean polygenic scores within 5-year interval age bins ( 2 SE). The x-axis indicates the
center of the age bin (except for the first and the last bins). The dashed line shows the
expected polygenic score based on the null model, accounting for confounding batch effects,
changes in ancestry, and the participant’s age, sex, year of birth, and the Townsend index
(a measure of socioeconomic status).
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Figure 1.28: Trajectories of polygenic scores with father’s age for traits associated with
paternal survival in the UK Biobank. Each plot shows (in blue) the mean polygenic score
( 2 SE) among the fathers who died in a 5-year interval centered around the plotted discs,
and (in black) the mean polygenic score among fathers alive up to a given age, i.e., all
fathers with age or age at death (if deceased) exceeding a given age. The dashed lines show
the expected changes in polygenic scores based on the null model. If there is no effect of
the score on survival at a given time (age), then the score among those who died (blue
disc) should be the same as the score among those who were alive at the previous time
interval. Thus, the divergence between the blue and the black lines in any time interval is
an indicator of the effect of the score on survival (and its direction) within that interval.
The precise effect, however, also depends on the total hazard rate of the sample, which
varies by age.
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Figure 1.29: Trajectories of polygenic scores with mother’s age for traits associated with
maternal survival in the UK Biobank. Same as Figure 1.28, but plotted for mothers (with
red instead of blue).
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Figure 1.30: Protective effect of later predicted puberty timing on survival in GERA
(p  6:7  10 3). Polygenic score for puberty timing with age of the participants. The data
points are the mean scores within 10-year interval age bins ( 2 SE). The x-axis indicates
the center of the age bin (except for the first and the last bins). The dashed line shows
the expected score based on the null model, accounting for confounding batch effects and
changes in ancestry.
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Figure 1.31: Testing for stabilizing selection on traits in the UK Biobank. Quantile-quantile
plots testing for a change in the squared difference of polygenic score from the mean with
fathers’ (A) and mothers’ (B) age at death, treating age variables as ordinal. 42 traits
were tested (see Table 1.2). The red line indicates the distribution of the p-values under
the null model.
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Figure 1.32: Power of the model to detect changes in allele frequency with age. Same as
Figure 1.1, but with 500,000 samples evenly distributed among age categories and only
showing the results using models with age treated as a categorical variable. As can be seen,
there should be substantial power to detect such effects even for relatively rare variants
(i.e., at a couple of percent frequency in the population).
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Figure 1.33: Association between variants influencing age at first birth and apparent fer-
tility in the UK Biobank (p  4:2  10 8). Polygenic score versus the number of siblings
for 112,130 participants with mother’s age  50 years. Data points are mean scores (
2 SE). The polygenic score was regressed on the number of siblings, accounting for the
confounding batch effects, changes in ancestry, and the participant’s age, sex, year of birth,
and the Townsend index (a measure of socioeconomic status). The dashed line shows the
expected score based on the null model.
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Figure 1.34: Ascertainment bias towards older participants for older parental age at death
categories. Fraction of the participants > 61 years old (last 3 age categories in Figure
1.23) in each parental age bin. Assuming parents of older participants on average belong
to earlier generations, older age at death categories will contain parents born earlier.
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Table 1.2: List of phenotypes and abbreviations. The numbers of loci passing quality
control measures are shown for each data set.
Trait Abbreviation #loci in UK Biobanka #loci in UK Biobankb #loci in GERA
Age at first birth AFB 10 10 10
Age at natural menopause ANM 53
Age at voice drop AVD 5
Alzheimer’s diseasec AD 4
Any allergies ALL 35
Asthma ATH 33 33 32
Beighton hypermobility BHM 17
Body mass index BMI 30 30 30
Bone mineral density (femoral neck) FNBMD 18
Bone mineral density (lumbar spine) LSBMD 20
Breast size CUP 14
Childhood ear infections CEI 13
Chin dimples DIMP 52
Coronary artery disease CAD 11 11 11
Crohn’s disease CD 58
Fasting glucose FG 15
Height HEIGHT 561
Hemoglobin HB 15
High-density lipoproteins HDL 45 45 46
Hypothyroidism HTHY 26
Low-density lipoproteins LDL 39 40 40
Male pattern baldness MPB 44
Mean cell hemoglobin concentration MCHC 15
Mean platelet volume MPV 29
Mean red cell volume MCV 41
Migraine MIGR 29
Nearsightedness NST 159
Nose size NOSE 10
Packed red cell volume PCV 12
Parkinson’s disease PD 23
Photic sneeze reflex PS 60
Platelet count PLT 49
Puberty timingd PT 359 358 359
Red blood cell count RBC 22
Rheumatoid arthritis RA 68
Schizophrenia SCZ 191
Tonsillectomy TS 38
Total cholesterol TC 49 51 51
Triglycerides TG 28
Type 2 diabetes T2D 11
Unibrow UB 53
Waist-hip ratio WHR 12
a: Among participants of British genetic ancestry.
b: Among participants of non-British genetic ancestry.
c: For AD the APOE locus was excluded.
d: Age at menarche associated variants were used to proximate puberty timing scores in both males and females
because of the strong genetic correlation between the timing of puberty in makes and females.
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Table 1.3: Results of the Cox model for association of polygenic scores for 42 traits with
survival of parents of the UK Biobank participants.
Trait Father Mother
Effect SE HR p-value Effect SE HR p-value
Puberty timing -0.0363 0.0080 0.96 6:2  10 6 -0.0278 0.0090 0.97 2  10 3
AD -0.0238 0.0205 0.98 0.25 0.0182 0.0228 1.02 0.42
AFB -0.0398 0.0180 0.96 0.03 -0.0639 0.0200 0.94 1:4  10 3
ALL -0.0096 0.0230 0.99 0.67 0.0245 0.0255 1.02 0.34
ANM 0.0015 0.0039 1.00 0.70 0.0102 0.0044 1.01 0.02
ATH 0.0279 0.0109 1.03 0.01 0.0149 0.0121 1.02 0.22
AVD 0.1032 0.0518 1.11 0.05 0.0370 0.0576 1.04 0.52
BHM 0.0020 0.0167 1.00 0.90 0.0162 0.0185 1.02 0.38
BMI 0.1996 0.0355 1.22 1:8  10 8 0.0823 0.0395 1.09 0.04
CAD 0.0784 0.0177 1.08 9  10 6 0.0892 0.0196 1.09 5:3  10 6
CD 0.0035 0.0039 1.00 0.37 0.0018 0.0043 1.00 0.68
CEI -0.0029 0.0204 1.00 0.89 0.0052 0.0227 1.01 0.82
CUP 0.0058 0.0149 1.01 0.70 -0.0206 0.0166 0.98 0.21
DIMP -0.0103 0.0061 0.99 0.09 0.0041 0.0068 1.00 0.55
FG 0.0438 0.0194 1.04 0.02 0.0123 0.0216 1.01 0.57
FNBMD 0.0212 0.0189 1.02 0.26 -0.0147 0.0210 0.99 0.48
HB 0.0610 0.0278 1.06 0.03 -0.0137 0.0307 0.99 0.66
HDL -0.0340 0.0139 0.97 0.01 -0.0605 0.0154 0.94 8:9  10 5
HEIGHT -0.0148 0.0083 0.99 0.08 0.0092 0.0092 1.01 0.32
HTHY 0.0073 0.0083 1.01 0.38 0.0024 0.0093 1.00 0.80
LDL 0.0806 0.0140 1.08 8:1  10 9 0.0844 0.0155 1.09 5:2  10 8
LSBMD 0.0167 0.0173 1.02 0.34 0.0168 0.0193 1.02 0.38
MCHC 0.0561 0.0260 1.06 0.03 0.0106 0.0289 1.01 0.71
MCV -0.0098 0.0118 0.99 0.40 0.0237 0.0131 1.02 0.07
MIGR -0.0176 0.0165 0.98 0.28 -0.0261 0.0182 0.97 0.15
MPB 0.0045 0.0041 1.00 0.27 0.0017 0.0046 1.00 0.70
MPV -0.0104 0.0091 0.99 0.25 0.0072 0.0101 1.01 0.48
NOSE 0.0070 0.0585 1.01 0.90 0.0240 0.0650 1.02 0.71
NST -0.0130 0.0072 0.99 0.07 0.0180 0.0080 1.02 0.02
PCV 0.0519 0.0284 1.05 0.07 -0.0411 0.0314 0.96 0.19
PD -0.0033 0.0094 1.00 0.73 -0.0012 0.0105 1.00 0.91
PLT 0.0100 0.0143 1.01 0.48 -0.0028 0.0159 1.00 0.86
PS 0.0147 0.0062 1.01 0.02 -0.0042 0.0069 1.00 0.54
RA 0.0092 0.0044 1.01 0.03 0.0124 0.0049 1.01 0.01
RBC 0.0215 0.0193 1.02 0.26 0.0117 0.0213 1.01 0.58
SCZ 0.0073 0.0054 1.01 0.18 0.0070 0.0061 1.01 0.25
T2D 0.0162 0.0117 1.02 0.17 0.0120 0.0131 1.01 0.36
TC 0.0901 0.0137 1.09 4:3  10 11 0.0679 0.0152 1.07 7:8  10 6
TG 0.0488 0.0160 1.05 2:2  10 3 0.0346 0.0177 1.04 0.05
TS 0.0005 0.0129 1.00 0.97 0.0278 0.0143 1.03 0.05
UB -0.0184 0.0202 0.98 0.36 0.0020 0.0224 1.00 0.93
WHR -0.0251 0.0502 0.98 0.62 0.0188 0.0559 1.02 0.74
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Table 1.4: Age dependency of hazard ratios for the top associations with parental survival
in the UK Biobank under the Cox model.
Trait Age range Father Mother
Effect size (SE) HR p-value Effect size (SE) HR p-value
Puberty timing > 75 -0.0167 (0.0129) 0.98 0.2 -0.0174 (0.0124) 0.98 0.16
 75 -0.0486 (0.0102) 0.95 2:1  10 6 -0.0390 (0.0130) 0.96 0.0027
AFB > 75 -0.0453 (0.0291) 0.96 0.12 -0.0399 (0.0276) 0.96 0.15
 75 -0.0370 (0.0229) 0.96 0.11 -0.0903 (0.0290) 0.91 0.0019
ATH > 75 -0.0122 (0.0176) 0.99 0.49 0.0130 (0.0168) 1.01 0.44
 75 0.0524 (0.0138) 1.05 1:5  10 4 0.0173 (0.0176) 1.02 0.32
BMI > 75 0.1658 (0.0575) 1.18 0.004 0.0659 (0.0545) 1.07 0.23
 75 0.2182 (0.0451) 1.24 1:3  10 6 0.0961 (0.0572) 1.1 0.093
CAD > 75 -0.0111 (0.0286) 0.99 0.7 0.0647 (0.0270) 1.07 0.017
 75 0.1337 (0.0224) 1.14 2:6  10 9 0.1150 (0.0284) 1.12 5:2  10 5
HDL > 75 -0.0304 (0.0225) 0.97 0.18 -0.0807 (0.0214) 0.92 1:6  10 4
 75 -0.0360 (0.0176) 0.96 0.041 -0.0394 (0.0224) 0.96 0.078
LDL > 75 0.0431 (0.0227) 1.04 0.058 0.1183 (0.0214) 1.12 3:3  10 8
 75 0.1030 (0.0177) 1.11 6:2  10 9 0.0487 (0.0225) 1.05 0.03
TC > 75 0.0490 (0.0222) 1.05 0.027 0.1014 (0.0210) 1.11 1:4  10 6
 75 0.1144 (0.0173) 1.12 4:2  10 11 0.0319 (0.0220) 1.03 0.15
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Table 1.5: Replication of associations in the discovery panel (UK Biobank individuals of
British ancestry) in the UK Biobank participants of non-British ancestry.
Trait Father Mother
Effect size (SE) HR p-value Effect size (SE) HR p-value
Puberty timing -0.0497 (0.0164) 0.95 0.0024 -0.0276 (0.0186) 0.97 0.14
AFB -0.0167 (0.0359) 0.98 0.64 -0.0277 (0.0409) 0.97 0.5
ATH 0.0296 (0.0204) 1.03 0.15 0.0253 (0.0228) 1.02 0.27
BMI 0.2240 (0.0719) 1.25 0.0018 0.2137 (0.0814) 1.24 0.0087
CAD 0.0466 (0.0354) 1.05 0.19 0.0578 (0.0399) 1.06 0.15
HDL -0.0168 (0.0276) 0.98 0.54 -0.0442 (0.0313) 0.96 0.16
LDL 0.0711 (0.0282) 1.07 0.012 0.0865 (0.0320) 1.09 0.0068
TC 0.0460 (0.0273) 1.05 0.092 0.0738 (0.0310) 1.08 0.017
82
Table 1.6: Testing for change in polygenic scores with age of the GERA participants.
Trait Beta (SE)(104) a p-value
Puberty timing 3.7 (1.4) 0.0067
AFB -0.69 (0.60) 0.25
ATH -0.41 (1.0) 0.7
BMI -0.26 (0.32) 0.42
CAD -1.1 (0.62) 0.088
HDL 0.042 (0.81) 0.96
LDL -0.65 (0.74) 0.38
TC -1.0 (0.78) 0.18
a: Linear regression slope coefficient (polygenic score per year).
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Chapter 2
Variable prediction accuracy of
polygenic scores within an ancestry
group
Published under: Mostafavi H.*, Harpak A.*, Conley D., Pritchard J.K., Przeworski
M. Variable prediction accuracy of polygenic scores within an ancestry
group. BioRxiv (2019); *Contributed equally.
2.1 Abstract
Fields as diverse as human genetics and sociology are increasingly using polygenic
scores based on genome-wide association studies (GWAS) for phenotypic prediction.
However, recent work has shown that polygenic scores have limited portability across
groups of different genetic ancestries, restricting the contexts in which they can be
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used reliably and potentially creating serious inequities in future clinical applications.
Using the UK Biobank data, we demonstrate that even within a single ancestry group,
the prediction accuracy of polygenic scores depends on characteristics such as the
age or sex composition of the individuals in which the GWAS and the prediction
were conducted, and on the GWAS study design. Our findings highlight both the
complexities of interpreting polygenic scores and underappreciated obstacles to their
broad use.
2.2 Introduction
Genome-wide association studies (GWAS) have now been conducted for thousands of
human complex traits, revealing that the genetic architecture is almost always highly
polygenic, i.e., that the bulk of the heritable variation is due to thousands of genetic
variants, each with tiny marginal effects [14, 15]. These findings often make it difficult
to interpret the molecular basis for variation in a trait, but they lend themselves
more immediately to another use: phenotypic prediction. Under the assumption
that alleles act additively, a “polygenic score” (PGS) can be created by summing the
effects of the alleles carried by an individual; this score can then be used to predict
that individual’s phenotype [37, 38]. For highly heritable traits, such scores already
provide informative predictions in some contexts: for example, prediction accuracies
are 24.4% for height [17] and up to 13% for educational attainment [48].
This genomic approach to phenotypic prediction has been rapidly adopted in three
distinct fields. In human genetics, PGS have been shown to help identify individuals
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that are more likely to be at risk of diseases such as breast cancer (e.g., [39, 40,
41, 42]). Based on these findings, a number of papers have advocated that PGS be
adopted in designing clinical studies, and by clinicians as additional risk factors to
consider in treating patients [39, 128]. In human evolutionary genetics, several lines of
evidence suggest that adaptation may often take the form of shifts in the optimum of
a polygenic phenotype and hence act jointly on the many variants that influence the
phenotype [129, 19, 130]. In this context, PGS are used to examine the evolutionary
history of the set of alleles known to impact a complex trait of interest, e.g., height
[19, 68, 33, 131, 132, 133]. Finally, in various disciplines of the social sciences, PGS
are increasingly used to distinguish environmental from genetic sources of variability
[43], as well as to understand how genetic variation among individuals may cause
heterogeneous treatment effects when studying how an environmental influence (e.g.,
a schooling reform) affects an outcome (such as BMI) [44, 45]. In these applications,
the premise is that PGS will “port” well across groups—that is that they remain
predictive not only in samples very similar to the ones in which the GWAS was
conducted, but also in other sets of individuals (henceforth “prediction sets”).
As recent papers have highlighted, however, PGS are not as predictive in individ-
uals whose genetic ancestry differs substantially from the ancestry of individuals in
the original GWAS (reviewed in [47]). As one illustration, PGS calculated in the
UK Biobank predict phenotypes of individuals sampled in the UK Biobank better
than those of individuals sampled in the BioBank Japan Project: for instance, the
incremental for height is approximately 11% in the UK versus 3% in Japan [47].
Similarly, using PGS based on Europeans and European-Americans, the largest ed-
86
ucational attainment GWAS to date (“EA3”) reported an incremental of 10.6% for
European-Americans but only 1.6% for African-Americans [48].
To date, such observations have been discussed mainly in terms of population genetic
factors that reduce portability [46, 49, 50, 51, 52, 53]. Notably, GWAS does not
pinpoint causal variants, but instead implicates a set of possible causal variants that
lie in close physical proximity in the genome. The estimated effect of a given SNP
depends on the extent of linkage disequilibrium (LD) with the causal sites [134, 15].
Thus, LD differences between populations that arose from their distinct demographic
and recombination histories will lead to variation in the prediction accuracy of phe-
notypes across populations [135]. Because of their distinct demographic histories,
populations also differ in the allele frequencies of causal variants. This problem is
particularly acute for alleles that are rare in the population in which the GWAS was
conducted but common in the population in which the trait is being predicted. Such
variants are likely to have noisy effect size estimates in the estimation sample or may
not be included in the PGS at all, and yet they contribute substantially to heritability
in the target population. Furthermore, causal loci or effect sizes may differ among
populations, for instance if the effect of an allele depends on the genetic background
on which it arises (e.g., [136]). For all these reasons, we should expect PGS to be less
predictive across ancestries.
In practice, given that most individuals (79%) included in current GWAS are of Euro-
pean ancestry [137, 47], PGS are systematically more predictive in European-ancestry
individuals than among other people. As a consequence, the clinical applications and
scientific understanding to be gained from PGS will predominantly and unfairly ben-
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efit a small subset of humanity. A number of papers have therefore highlighted the
importance of expanding GWAS efforts to include more diverse ancestries [138, 47,
139, 52, 53].
Importantly, factors other than ancestry could also impact the accuracy and porta-
bility of PGS. For example, the educational attainment of an individual depends not
only on their own genotype, but on the genotypes of their parents, due to nurtur-
ing effects [54], and of their peers, due to social genetic effects [55], as well as of
course on non-genetic factors. Also, traits such as height and educational attain-
ment show strong patterns of assortative mating, which can distort estimated effect
sizes in GWAS [56, 57, 58]. To what extent these effects remain the same across
cultures and environments is unknown, but if they differ, so will the prediction ac-
curacy. More generally, while we still know little about GxE (genotype-environment
interactions) in humans, GxE effects are well-documented in other species—notably
in experimental settings—and would further reduce the portability of PGS across
environments [59, 60, 140]. In addition, environmental variance could differ between
groups, which would change the proportion of the variance in the trait explained by
a PGS (i.e., the prediction accuracy) even in the absence of genetic differences or
GxE effects. Finally, PGS for some traits may include a component of environmental
or cultural confounding associated with population structure [33, 34, 141, 142, 143].
This source of confounding can increase or decrease prediction accuracy, depending
on the structure in the prediction samples.
Given these considerations, it is important to ask to what extent PGS are portable
among groups within the same ancestry. To explore this question, we stratified the
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subset of UK Biobank samples designated as “White British” (WB) according to
some of the standard sample characteristics of GWAS studies: the ages of the indi-
viduals, their sex, and socio-economic status. We chose to focus on these particular
characteristics because they vary widely among GWAS samples depending on sam-
ple ascertainment procedures. Furthermore, these characteristics have been shown
to influence heritability for some traits in a study of a subset of the UK Biobank
[144], raising the possibility that these choices also influence prediction accuracy.
Indeed, for three example traits, we show that there exist major differences in the
prediction accuracy of the PGS among these groups, even though they share highly
similar genetic ancestries. For a variety of traits, we further demonstrate that pre-
diction accuracy differs markedly depending on whether the GWAS is conducted in
unrelated individuals or in pairs of siblings, even when controlling for the precision of
the estimates. This finding is again unexpected under standard GWAS assumptions;
it underscores the importance of genetic effects that are included in estimates from
some study designs and not others and highlights underappreciated challenges with
GWAS-based phenotypic prediction.
At present, it is difficult to fully determine the reasons why we see such variable pre-
diction accuracy across these strata and study designs. Contributing factors probably
include indirect genetic effects from relatives, assortative mating, varying levels of en-
vironmental variance, GxE interaction effects and perhaps undetected environmental
confounding. Nonetheless, our results make clear that the prediction accuracy of PGS
can be affected in unpredictable ways by known—and presumably unknown—factors
in addition to genetic ancestry.
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2.3 Results
2.3.1 Sample characteristics of the GWAS and prediction
set can influence prediction accuracy even within a
single ancestry
We examined how PGS for a few example traits port across samples that are of similar
genetic ancestry but differ in terms of some common study characteristics, e.g., the
male:female ratio (henceforth “sex ratio”), age distribution, or socio-economic status
(SES). To this end, we limited our analysis to the largest subset of individuals in the
UKB with a relatively homogeneous ancestry: 337,536 unrelated individuals that were
characterized by the UKB as “White British” (WB) [28]. In all analyses, we further
adjusted for the first 20 principal components of the genotype data, to account for
any population structure within this set of individuals (Materials and Methods).
In all analyses, we randomly selected a subset of individuals to be the prediction
set; we then conducted GWAS using the remaining individuals and built a PGS
model by LD-based clumping of the associations (Materials and Methods). To
examine the reliability of the prediction, we considered the incremental , i.e., the
increment obtained when adding the PGS to a model with only covariates (referred
to as “prediction accuracy” henceforth). Whether this measure is appropriate depends
on how PGS are to be used; it is not an obvious choice in human genetics, where
the goal is often to identify individuals at high risk of developing a particular disease
(i.e., in the tail of the polygenic score distribution). Nonetheless, because it has been
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widely reported in discussions of portability across genetic ancestries (e.g., [48, 47]),
we also used it here.
As a first case, we considered the prediction accuracy of a PGS for diastolic blood
pressure in prediction sets stratified by sex, motivated by reports that variation in
this trait may arise for somewhat distinct reasons in the two sexes [145, 146]. We
randomly selected males and females as prediction sets (20K individuals each), and
used the rest of the individuals for GWAS, matching the numbers of females and
males in the GWAS set. Adjusting for mean sex effects and medication use (see
Materials and Methods), the prediction accuracy is about 1.31-fold higher for
females than for males (Mann-Whitney p = 1:4  10 11; Figure 2.1A). Thus, despite
equal representation of males and females in the GWAS set, the prediction accuracy
varies depending on the sex ratio of prediction samples. To examine this further,
we repeated the same analysis but performed the GWAS in only one sex. When
the GWAS is conducted only in females, the prediction accuracy is about 1.43-fold
higher for females than for males; in turn, when GWAS was done in only males, the
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Figure 2.1: Variable prediction accuracy even within an ancestry group. Shown are incre-
mental R2 values (i.e., the increment in R2 obtained by adding a polygenic score predictor
to a model with covariates alone) in different prediction sets. Each box and whiskers plot
is computed based on twenty choices of estimation and prediction sets. Thick horizontal
lines denote the medians. (A,C,E) The polygenic scores were estimated in large samples of
unrelated WB individuals. Phenotypes were then predicted in distinct samples of unrelated
WB individuals, stratified by sex (A), age (C) or Townsend deprivation index, a measure of
SES (E). (B,D,F) Same as in A,C,E, but here the polygenic scores are based on a GWAS in
a sample limited to one sex, age or SES group. When the GWAS is performed in the group
that showed higher prediction accuracy in A,C,E (women, young, low SES), the qualitative
trend is the same; but when the GWAS is performed in men, old or high SES, prediction
accuracy is diminished and similar across groups.
We then considered two other cases, evaluating prediction accuracy in groups strati-
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fied by age for BMI and by adult socio-economic status (SES) for years of schooling,
using the Townsend deprivation index as a measure; our choices were motivated by
prior evidence suggesting that these characteristics of the GWAS can influence her-
itability [147, 148, 149, 144, 150]. We withheld a random set of 10K individuals in
each quartile of age and SES for prediction and performed GWAS using the remain-
ing individuals, matching the sample sizes across quartiles in the GWAS set. Similar
to our observation for diastolic blood pressure, the prediction accuracy varies across
prediction sets: it is 1.25-fold higher for BMI in the youngest quartile compared
to the oldest (Mann-Whitney p = 1:7  10 8; Figure 2.1C), and 1.69-fold higher for
years of schooling in the lowest SES quartile compared to the highest (Mann-Whitney
p = 1:4  10 11; Figure 2.1E). Furthermore, the differences across groups are again
sensitive to the choice of the GWAS set: the differences are marked when GWAS
is restricted to the youngest quartile for BMI and the lowest SES quartile for years
of schooling, but diminished when the GWAS is performed in the oldest and the
highest SES quartiles for BMI and years of schooling, respectively (Figure 2.1D,F).
These results remained qualitatively unchanged when we used instead of incremental
to measure prediction accuracy (Figure 2.4).
In these analyses, we used a p-value threshold of for inclusion of a SNP in the PGS.
The choice of how stringent to make the GWAS p-value threshold is important but
somewhat arbitrary, with approaches ranging from requiring genome-wide significance
to including all SNPs [151, 152, 153, 154, 155, 25, 133]. Often, this threshold is chosen
to maximize prediction accuracy in an independent validation set. When the goal
is to compare prediction performance across different groups, there is no obvious
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optimal choice of the p-value threshold. As we show, however, the qualitative trends
reported in Figure 2.1 do not depend on the p-value threshold choice (Figure 2.5).
These results pertain to three exemplar traits and do not speak to the prevalence of
this phenomenon. Nonetheless, they demonstrate that the portability of a polygenic
score can vary markedly depending on sample characteristics of both the original
GWAS and the prediction set, even within a single ancestry, and that the variation
in prediction accuracy across strata can be substantial; in fact, on the same order
as reported for different continental ancestries within the UK Biobank [47]. As one
example, the prediction accuracy in East Asian samples, averaged across a number of
traits, is about half of that in European samples when GWAS was European-based;
when the GWAS is done in the lowest SES group for years of schooling, prediction
accuracy in the highest SES group is less than half of that in the lowest SES (Figure
2.1F). Moreover, whereas for these traits, we had prior information about which
characteristics may be relevant, other aspects that vary across sets of individuals are
undoubtedly important as well (e.g., smoking behavior and diet may modify genetic
effects on lipid traits; [156, 157]), and for any given trait of interest, much less may
be known a priori.
Possible explanations for the variable prediction accuracy. Our goal in this
paper is to highlight that prediction accuracies can vary across groups of highly simi-
lar ancestry, rather than to investigate the likely causes for any particular phenotype.
Nonetheless, it is worth noting a couple of possibilities. Perhaps the simplest expla-
nation for our findings is that prediction accuracies vary only because of differences
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in the extent of environmental variance, while the genetic variance is more or less
constant. Indeed, the SNP heritabilities vary markedly across strata (see also [144]),
and the prediction accuracies track heritability differences (Figure 2.2A,B,C). For
all three traits, however, the estimated SNP heritability increases or remains the same
with increasing phenotypic variance, in contrast to what would be expected under a
model with a fixed genetic variance across strata (Figure 2.2D,E,F).
Another possibility is that there is an interaction between genetic effects and sam-
ple characteristics, for instance that different sets of genetic variants contribute to
blood pressure levels in males and females or to BMI across different stages of life.
This explanation is not supported by bivariate LD-score regression, which indicates
that the genetic correlations across strata are close to 1 (Table 2.2; Materials and
Methods). Yet when we re-estimate individual SNP effects in the prediction sets for
SNPs ascertained in the original GWAS, the estimated effects of trait-increasing alle-
les are larger in the groups with higher prediction accuracy (Figure 2.6; Materials
and Methods). A possible way to reconcile these findings is if effect sizes are highly
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Figure 2.2: Differences in environmental variance alone do not explain the variable predic-
tion accuracy. (A,B,C) The x-axes show heritability estimates ( SE) based on LD-score
regression in each set. The y-axes show incremental R2 values as in Figure 2.1A,C,E.
‘Q’ denotes quartile of age and SES in (B) and (C), respectively. Throughout, prediction
accuracy largely tracks SNP heritability. (D,E,F) The x-axes show phenotypic variance
estimates ( SE) across strata after adjusting for covariates (sex, age and 20 PCs). If the
heritability differences across strata are due to differences in environmental variance alone,
with genetic variance constant, then heritability should be inversely proportional to phe-
notypic variance. However, the best fitting model for this inverse proportionality (dashed
line) provides a poor fit.
Other factors complicate interpretation, however, and may also contribute to our ob-
servations. In particular, for the case of educational attainment, conditioning on adult
SES induces a form of range restriction, which could contribute to variable predic-
tion accuracy across strata. We note, however, that we see highly variable prediction
accuracies across SES strata even when the GWAS is conducted in all individuals
(Figure 2.1E); in that regard, our approach mimics what happens in practice when
polygenic scores are used to predict phenotypes in a sample with a smaller range of
SES (e.g., [158]). More generally, although this type of range restriction is artificially
amplified in our example, SES differences will often be a problem for GWAS in which
the sample is not representative of the population; for instance, the most recent major
GWAS of educational attainment [48] included numerous medical data sets and the
23andMe data set, which are not representative of the national population.
Another potentially important factor is that the adjustment for PCs may not be a
sufficient control for the different ways in which population structure can confound
GWAS results [159], leading to variable prediction accuracy across strata if they differ
in their population structure. To examine this possibility, we repeated the analysis
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in Figure 2.1B,D,F but using a linear mixed model (LMM) approach (including
PCs among other covariates; see Materials and Methods), and obtained qualitatively
similar results (Figure 2.7). Although not a perfect fix [160, 161], the fact that we
obtain similar results using PCs and LMM suggests that confounding due to popula-
tion stratification in the UK Biobank alone does not explain the variable prediction
accuracies across strata.
2.3.2 Potential portability obstacles explored through a
comparison of standard and family-based GWAS
Beyond sample characteristics, a number of factors may shape the portability of scores
across groups of similar ancestry. Standard GWAS is done in samples of individuals
that deliberately exclude close relatives; as implemented, it detects direct effects of the
genetic variants, but can also detect any indirect genetic effects of parents, siblings,
or peers, effects of assortative mating among parents, and potentially environmental
differences associated with fine scale population structure [54, 162, 48, 163, 33, 57, 58].
Given that many of these effects are likely to be culturally mediated (e.g., [164, 165]),
it seems plausible that they may vary within as well as across groups of individuals
with different ancestries. To the extent that they contribute to GWAS estimates and
hence to PGS, they may lead to differences in the prediction accuracy in samples
unlike the original GWAS.
To demonstrate that these considerations are not just hypothetical, we compared
the prediction accuracy when the PGS is trained on “unrelated” individuals such as
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those used in a standard GWAS to one obtained from a sibling-based (or “sib-based”)
GWAS (Materials and Methods). In the latter, genotype differences between sibs—a
result of random Mendelian segregation in the parents—are tested for association
with the phenotypic difference between them. Because the tests depend on pheno-
typic differences between siblings who, of course, have the same parents, these tests
are conditioned on the parental genotypes. Hence, they exclude many of the indirect
effects signals that may be picked up in standard GWAS (Supplementary Materi-
als). Differences between standard and sib-based GWAS are thus informative about
the relative importance of factors other than direct genetic effects [36, 163, 48, 33,
165].
A challenge in this comparison is that the UKB contains about 22K sibling pairs,
about 19K of which fall in the designation “White British” (WB). The siblings are
similar to the unrelated individuals in terms of ages, SES distributions and genetic
ancestries (Figures 2.8,2.9) but include a higher proportion of females; this differ-
ence is unlikely to influence our analyses (see below). While a large number, 19K
pairs is still too few to have adequate power to discover trait-associated SNPs, when
compared to a standard GWAS using the much larger sample of unrelated WB indi-
viduals (340K).
To increase power and enable a direct comparison between the two designs, we split
the SNP ascertainment and effect estimation steps as follows (Figure 2.3A): we
identified SNPs using a standard GWAS with a large sample size (median 270K
across the traits considered) (see Materials and Methods). We then estimated the
effect of each significant SNP using (i) a sib-based association test and (ii) a standard
99
association test. We chose the size of the estimation set in (ii) such that the median
standard error of effect estimates in (i) and (ii) is approximately equal. We then
compared the prediction accuracy of the two PGS obtained in this way (“standard
PGS” and “sib-based PGS”) in an independent prediction set of unrelated individuals;
as we show in the Supplementary Materials, our approach leads to highly similar
prediction accuracies of the two approaches under a model with direct effects only
(see Materials and Methods for details). A further advantage is that the two scores
are compared for the same set of SNPs, such that LD patterns and allele frequencies
do not come into play.
We applied the approach to 22 traits, focusing on traits with relatively high heritabil-
ity estimates as well as social and behavioral traits that have been the focus of recent
attention in social sciences. For the majority of the traits, such as diastolic blood
pressure, BMI, and hair color, the prediction accuracies of standard and sib-based
PGS were similar, as expected under standard GWAS assumptions and as observed
for two traits simulated under these assumptions (Figure 2.3B). However, for a
range of social and behavioral traits, such as years of schooling completed, pack years
of smoking and age at first sexual intercourse, the prediction accuracy of the sib-
based PGS was substantially lower than that of the standard PGS (Figure 2.3B).
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Figure 2.3: Comparison of prediction accuracy of standard and sib-based polygenic scores.
(A) After ascertaining SNPs in a large sample of unrelated individuals, we estimated the
effect of these SNPs with a standard regression using unrelated individuals and, indepen-
dently, using sib-regression. We then used the polygenic scores for prediction in a third
sample of unrelated individuals. We chose the sample size of the standard PGS estimation
set such that median effect estimate SEs are equal in the two designs, thereby ensuring equal
prediction accuracy under a vanilla model with no indirect effects or assortative mating.
Numbers in parentheses are median sample size in each set across 22 traits in Table 2.1
(see Table 2.3 for sample sizes for each trait). (B) Ratio of prediction accuracy in the two
designs across 22 traits. For each trait, we performed 10 resampling iterations of unrelated
individuals into three sets for discovery, estimation and prediction (small points). Large
points show mean values. (C-H) We repeated this procedure with different discovery-set
p-value thresholds for including a SNP in the polygenic score. The higher the p-value
threshold is, the more SNPs are included. For each p-value threshold, points show 10 iter-
ations as described and lines show mean values. Shown are a subset of traits, with traits
appearing in (B) but not shown here presented in Figure 2.13.
A number of factors could contribute to the difference between prediction accura-
cies for PGS based on sibs versus unrelated individuals, including residual effects of
population stratification, indirect genetic effects from parents and assortative mat-
ing. The relative importance of each factor will vary across traits [135, 54, 141, 58,
165]; for educational attainment, this gap is likely to reflect at least in part the doc-
umented contribution of indirect genetic effects to the standard PGS [48, 54, 162].
We show in the Supplementary Materials that in the presence of indirect genetic
effects mediated through parents, standard PGS outperforms sib-based PGS unless
direct and indirect effects are strongly anticorrelated (Figure 2.10), which seems
unlikely to be the case for years of schooling. The difference in the performance of
sib-based and standard PGS observed for other social and behavioral outcomes, such
as household income and age at first sexual intercourse (Figure 2.3B), may reflect
a similar phenomenon. An additional contribution to divergent prediction accuracies
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could come from sibling indirect effects, which contribute differentially to standard
and sibling-based PGS.
For height, there may be an important contribution of assortative mating to the
difference in prediction accuracies [36, 57, 48]. In the Supplementary Materials,
we show that under a simple model of positive assortative mating (mating of similar
individuals), the prediction accuracy based on a standard PGS is better than that of
a sib-based PGS (Figure 2.11). The difference in the performance of sib-based and
standard PGS observed for whole body water mass (Figure 2.3B) could possibly
reflect the same underlying effects of assortative mating, especially considering the
high genetic correlation between the two traits (by bivariate LD score regression,
g  0:66; p < 10 30). We further confirmed that the difference in the sex ratio of the
siblings and unrelated individuals, mentioned earlier, has a negligible effect on these
differences (Figure 2.12).
Thus, in comparisons of the prediction accuracies for PGS derived from standard and
sib-based association tests, many traits, notably behavioral ones, show substantial
differences in performance. We caution that while lower prediction accuracies for
PGS based on sib-based GWAS suggest that assortative mating or indirect effects
play a substantial role, the magnitude of the ratio also depends on other features
of the comparison like the sample sizes used (see Supplementary Materials). By
matching the sampling errors of the two approaches (Figure 2.3A), we ensure that
prediction accuracies are comparable in the absence of complications such as assorta-
tive mating or indirect effects. But in the presence of these complications, the relative
prediction accuracies will depend on sample sizes and on the contributions of envi-
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ronmental, direct and indirect genetic components to phenotypic variance. Indeed,
we show in the Supplementary Materials that in the presence of indirect genetic
effects or assortative mating, the difference in prediction accuracies between the two
approaches stems in part from the noise-to-signal ratio for sib-based versus standard
GWAS. An implication is that the gap between the prediction accuracy of sib-based
and standard PGS should depend on the number of SNPs included in the polygenic
scores (Figures 2.10,2.11).
Motivated by these considerations, we examined how the prediction accuracy varies
when progressively relaxing the GWAS p-value threshold for inclusion of SNPs, i.e.,
when including more weakly associated SNPs in the PGS. (In Figure 2.3B, re-
sults are shown for the p-value threshold that maximizes the prediction accuracy of
the standard PGS, replicating the practice when comparing populations of different
ancestry [47].) For hair color and blood pressure, there is little to no difference in
prediction accuracy between the two estimation methods, regardless of the number of
SNPs included in the score (Figure 2.3C,D). In contrast, for height and whole body
water mass, although standard and sib-based PGS perform similarly when based on
the most significantly associated SNPs, standard PGS progressively outperforms sib-
based PGS when more SNPs are included (Figure 2.3E,F). Similarly, the difference
in prediction accuracy between sib-based and standard PGS changes markedly for
years of schooling, household income and other social and behavioral traits (Figure
2.3G,H and Figure 2.13). The growing gap in performance with increasing p-value
threshold likely reflects a combination of an increasing noise-to-signal ratio in the sib-
based PGS (see Supplementary Materials) and changes in the relative importance
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of direct effects versus other factors such as indirect parental effects and assortative
mating.
In summary, the differences between the prediction accuracies of standard and sib-
GWAS seen for a number of traits (Figure 2.3B) demonstrate that standard GWAS
estimates often include a substantial contribution of factors other than direct effects.
In these cases, even if the power to detect direct effects were comparable, standard
GWAS would lead to higher prediction accuracy than sib-GWAS. In some contexts
that may be a sufficient reason to rely on PGS derived from standard GWAS. However,
that gain stems from the inclusion of factors such as indirect effects and assortative
mating that are likely to be modulated by SES, environment and culture (e.g., [164,
165]). Thus, the increased prediction accuracy likely comes at a cost of not always
porting well across groups, even of the same ancestry, in ways that may be difficult
to anticipate.
2.4 Implications
Although the conversation around the portability of PGS has largely focused on ge-
netic ancestries, our results show that prediction accuracy can also differ, at times to a
comparable extent, among groups of similar ancestry—even due to basic study design
differences such as age and sex composition. If only due to increased environmental
variance, such decreased accuracy would be acceptable, at least for certain applica-
tions. But as we have shown, differences in the degree of environmental variance are
not the primary explanation for the patterns we report (Figure 2.2), and other fac-
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tors, including differences in the magnitude of genetic effects among groups, indirect
effects and assortative mating, also lead to differences in the prediction accuracy of
PGS, in ways that may make applications of phenotypic prediction problematic, even
within a single ancestry group.
Following the discussion of portability across ancestries, we have focused on incremen-
tal R2 as a measure of portability, and it remains unknown to what extent the same
issues also impact the use of PGS in reliably identifying individuals in the tails of the
distribution, i.e., those at elevated risk of developing a disease—the main application
of PGS in human genetics, as distinct from social science or evolutionary biology.
Nonetheless, the same concerns are likely to apply, especially when the magnitude of
genetic effects depends on GWAS characteristics.
In any case, these results make clear that the question of the domain over which a
PGS applies is not just about population genetic parameters such as LD patterns
and allele frequencies or GxG effects but also the extent of environmental variance,
GxE, as well as the contribution of direct effects versus indirect effects, assortative
mating and environmental confounding. An important implication is that differences
in prediction accuracies among groups with distinct ancestries cannot be interpreted
exclusively or even primarily in terms of population genetic parameters when these
groups differ dramatically in their SES [166, 167, 168, 169] and other factors that
may affect portability—especially when the relative contribution of these factors to
GWAS signals remains unknown. Thus, efforts to conduct GWAS in groups that
vary in ancestry and geographic locations will need to be accompanied by a careful
examination of variation in portability along other dimensions.
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In that regard, it is worth noting that while classical twin studies were often con-
stituted to be representative of a reference population (often national in nature)
[147, 170], the same is not true of most contemporary human genetic datasets, which
are skewed towards medical case-control studies, biobanks that are opt-in (and thus
tend to be wealthier and better educated than the population average) or direct-
to-consumer proprietary genetic databases (which are even more skewed along these
dimensions) [48]. For instance, individuals in UK Biobank have higher SES than the
rest of the British population [171] and are presumably self-selected for a certain level
of interest in biomedical research. These factors alone raise challenges as to the broad
portability of PGS derived from them.
One fruitful way forward may be to study data from related individuals, in which it
should be possible to decompose the components of the signals identified in GWAS
into direct and indirect effects, the degree of assortative mating and the contribution
of residual stratification [162, 54, 172]. Not only will this decomposition help us to
better interpret the results of GWAS and the resulting PGS, it will make it possible
to examine under which circumstances, and for which phenotypes, components port
more reliably to other sets of individuals, both unrelated and related. Ultimately, we
envisage that in order to be broadly applicable, GWAS-based phenotypic prediction
models will need to include not only a PGS but some study characteristics, other
social and environmental measures and, perhaps crucially, their interactions.
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2.5 Materials and Methods
UK Biobank.
The UK Biobank (UKB) is a large study of about half a million United Kingdom
residents, recruited between 2006 to 2010 [28]. In addition to genetic data, hundreds
of phenotypes were collected through measurements and questionnaires at assessment
centers, and by accessing medical records of the participants.
Inclusion criteria. In this study, we focused on 408,494 participants who
passed quality control (QC) measures provided by UKB; specifically, for whom the
reported sex (QC parameter “Submitted.Gender”) matched their inferred sex from
genotype data (QC parameter “Inferred.Gender”); who were not identified as outliers
based on heterozygosity and missing rate (QC parameter “het.missing.outliers”==0);
and did not have an excessive number of relatives in the database (QC param-
eter “excess.relatives”==0). We further restricted ourselves to those individu-
als identified by UKB to be of “White British” (WB) ancestry (QC parameter
“in.white.British.ancestry.subset”==1), which is a label that refers to those who,
when given a set of choices, self-reported to be of “White” and “British” ethnic back-
grounds and, in addition, were tightly clustered in a principal component analysis of
the genotype data, as detailed in [28]. For a given trait, we further conditioned on
individuals for which measurement or report of the trait value was available.
Phenotype data.
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We focused on 22 traits, including traits with relatively high heritability estimates as
well as social and behavioral traits that have been the focus of recent attention in so-
cial sciences (see Table 2.1 for a complete list and description of the phenotypes used
in this work, and their corresponding numeric field codes in the UKB data showcase).
We calculated the phenotype “years of schooling” by converting the maximal educa-
tional qualification of the participants to years following Okbay et al. [173] (Table
2.4). For diastolic blood pressure, pulse rate, and forced vital capacity, we took the
average of the first two rounds of measurement taken during the same examination
at UKB assessment centers. We adjusted the diastolic blood pressure levels for blood
pressure lowering medication following Evangelou et al. [174] by shifting the values
upward by 10 mmHg for individuals taking medication. For hand grip strength, we
took the average of the measurements for the two hands. For categorical phenotypes,
we assigned integer values to each category (Table 2.1). For hair color, individuals
who reported hair color variable “Other” were excluded from the analyses. For a
subset of individuals, multiple measurements of a phenotype were provided, corre-
sponding to multiple visits to UKB assessment centers; in those cases, we used the
measurements during the first visit.
Genotype data.
UKB participants were genotyped on either of two similar genotyping arrays, UK
Biobank Axiom and UK BiLEVE arrays, at a total of 850K markers. We focused
on autosomal bi-allelic SNPs shared between both arrays, and used plink v. 1.90b5
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[116] to filter SNPs with calling rate > 0:95, minor allele frequency > 10 3, and
Hardy-Weinberg equilibrium test p-val > 10 10 among the WB samples, resulting in
616,323 SNPs.
GWAS and trait prediction methods.
GWAS by sample characteristics. We focused on a set of 337,536 WB sam-
ples that were identified by the UKB to be “unrelated” (sample QC parameter
“used.in.pca.calculation”==1 as provided by UKB), defined such that no pairs of
individuals are inferred to be 3rd degree relatives or closer. We split the sample
into non-overlapping sets of individuals by one of the following factors: age at re-
cruitment (in years), sex, and Townsend deprivation index at recruitment (used as
a proxy for socioeconomic status or SES). For the Townsend deprivation index and
age, we divided into four sets: Q1 [minimum value, first quartile], Q2 (first quartile,
second quartile], Q3 (second quartile, third quartile], and Q4 (third quartile, maxi-
mum value]. We randomly selected 10K samples in each SES and age group, and 20K
of males and 20K of females as held-out prediction sets, and performed GWAS using
the remaining samples, matching sample sizes across groups in the GWAS set. We
performed nine GWAS: for years of schooling in SES Q1 and SES Q4 (sample size
73,298 for each), and in the pooled sample of all four groups (sample size 293,192);
for body mass index (BMI) in Q1 and Q4 (sample size 72,343 for each), and in pooled
sample of all four groups (sample size 272,508); and for diastolic blood pressure in
males and females (sample size 122,791 for each), and in a pooled sample of males and
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females (sample size 245,582). We performed all GWAS using plink v. 2.0 (with flag:
–linear), adjusting for sex, age and first 20 PCs as covariates. PCs are principal com-
ponents of the all genotype data, not just WB, as provided by UKB (calculated using
the whole cohort, not just WB). For a subset of cases, (where GWAS was performed
in samples restricted by characteristics described above), we additionally performed
association tests using a linear mixed model (LMM) as implemented in BOLT-LMM
v. 2.3.2 [175], using LD scores computed from 1000 Genomes European-ancestry
samples, with sex, age and first 20 PCs as covariates. The GWAS summary statistics
were used to construct PGS for the samples in the prediction sets.
To better understand the performance of PGS across the strata (see “Possible expla-
nations for the variable prediction accuracy”), we estimated the mean effect sizes of
significant SNPs in each strata. To avoid overfitting, we first performed an associa-
tion test in the pooled sample of all strata; then for significantly associated SNPs, we
re-estimated the effect sizes in each of the strata. We performed 20 iterations of all
above steps (Figure 2.1 and Figures 2.4-2.7).
We also considered two binary phenotypes (i) attained a college degree or not and
(ii) attained any degree or not, for the analysis of educational attainment by SES
(as described above for years of schooling), confirming that our analysis is robust to
how education phenotype is coded (Figure 2.14). For these traits we used a logistic
regression model for GWAS (using plink v. 2.0 with flag: –logistic).
Standard versus sibling-based regression. We used the genetic relatedness
information provided by UKB to infer sibling pairs among the WB samples. Following
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Bycroft et al. [28], we marked pairs with and IBS0 > 0:0012 as siblings, where is
the estimated kinship coefficient and IBS0 is the fraction of loci at which individuals
share no alleles. By this approach, we identified 19,335 sibling pairs including 35,464
individuals across 17,305 families. For a given trait, we included pairs with the
property that trait values for both individuals were reported. We then formed two
sets of individuals: “Siblings” set, including the sibling pairs randomly sampled to
include only one pair per family, and an “Unrelateds” set, including the unrelated
individuals identified by the UKB (see section “GWAS by sample characteristics”
above), but excluding the Siblings and 7,409 individuals that were related to the
Siblings (3rd degree or closer).
We focused on 22 traits (Table 2.1) and two simulated traits (see below). For each
trait, we first downsampled the Unrelateds to a sample size such that the median
standard error of effect estimates roughly matched the median standard error in the
sibling-based regression (see “Estimating n” below). We then divided the Unrelateds
set into three non-overlapping sets: after sampling individuals (Unrelateds- set), we
randomly split the rest of the Unrelateds set into an Unrelateds-prediction set (10%
of the samples) to be used as a sample for trait prediction (“prediction set”), and an
unrelated individuals discovery set (90% of the samples) to be used for the discovery
of trait associated variants (see Table 2.3 for sample sizes in each set). For each trait,
we performed standard GWAS in the Unrelateds-discovery set, and ascertained SNPs
by thresholding on association p-values. We then estimated the effect sizes for these
ascertained SNPs in two ways: by a sibling-based association test in the Siblings
set (using plink v. 1.90b5’s QFAM procedure; flag: –qfam), and by a standard
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association test in the Unrelateds- set (using plink v. 2.0). Subsequently, for each
set of ascertained SNPs in the Unrelateds-discovery set, two PGS were constructed
for the samples in the Unrelateds-prediction set (see Figure 2.3A for overview of
the pipeline). We performed 10 iterations of the above sampling, ascertainment and
estimation steps.
Estimating n. In order to compare the performance of sibling-based and standard
GWAS designs, we wanted to match both analyses to have similar prediction accuracy
under a vanilla model of no assortative mating, population structure stratification
or indirect effects. In the Supplementary Materials, we show that this could
be achieved by matching median effect estimate standard errors. For each trait,
we therefore calculated , the sample size of a standard GWAS that yields roughly
equal standard errors in the standard and sibling-based regressions. Specifically,
for each trait, we first performed sibling-based GWAS in the Siblings using plink’s
QFAM procedure (using the flag: –qfam mperm=100000 emp-se). We then randomly
sampled a range of sample sizes from the set of Unrelateds, from 5K to 20K in 1K
increments. Following Wood et al. [36], for each sample size, we performed a standard
GWAS, and investigated the linear relationship between the square root of the sample
size and the inverse of the median standard error of the effect size estimates. We then
used this linear relationship to estimate the sample size of a standard GWAS that
corresponds to the inverse of the median standard error of the effect sizes estimate in
the sibling-based GWAS.
All standard association tests were performed using plink v. 2.0 (using the flag:
–linear), adjusting for sex, age and first 20 PCs as covariates. For sibling-based
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association tests we first residualized the phenotypic values on the same covariates,
and then regressed the sibling differences in residuals on sibling genotypic differences
using plink’s QFAM procedure as described above.
We also considered a version of the analysis described above, in which we first resid-
ualized the phenotypes on covariates in the pooled sample of all WB individuals, and
then ran the pipeline on the residuals without further adjustment for covariates in the
GWAS or prediction evaluation. As shown in Figure 2.15, this approach produced
results that are qualitatively the same to what we present in Figure 2.3.
Simulated traits. We wanted to check that given the study design described above,
sibling-based and standard GWAS perform similarly with respect to trait prediction,
under the vanilla model of no population stratification, assortative mating or indirect
genetic effects (Figure 2.3). To this end, we simulated two traits with heritability
h2 = 0:5 and (i) m = 10; 000 causal loci, and (ii) m = 1; 000; 000 causal loci.
We randomly selected the causal SNPs from a set of 10,879,183 imputed SNPs, con-
sidering that most causal variants are plausibly not directly genotyped on SNP ar-
rays. We used a set of SNPs that passed quality control procedures by the Neale lab
(http://www.nealelab.is/uk-biobank), namely autosomal SNPs, imputed using the
haplotype reference consortium (HRC) panel, which have INFO score > 0:8 and have
minor allele frequency > 10 4; we further limited the SNP set to ones that were bi-
allelic in the WB sample. As in Martin et al. [46], we randomly assigned effect sizes
to these causal SNPs as   N(0; h2/m), and zero for non-causal SNPs. We then
calculated genetic component of the trait, g, for all WB samples under an additive
model by summing the allelic counts weighted by their effect sizes using plink (using
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the flag: –score). Allelic counts were determined by converting imputation dosages
to genotype calls with no hard calling threshold. We also assigned environmental





where Xi is the number of minor alleles at SNP i carried by the individual, and the









1  h2   

;
where bars represent averages, g is the standard deviation of PGS across individuals
and  is the standard deviation of environmental contributions across individuals.
These simulated traits were then analyzed using the same pipelines as the other
traits (e.g., adjusting for covariates etc.). Importantly, SNP discovery and effect size
estimations in GWAS were performed without knowledge of the causal SNPs.
Polygenic score (PGS) construction and trait prediction. For all GWAS
designs described above, we used p-value thresholding followed by clumping to choose
sets of roughly independent SNPs to build PGS. We considered a logarithmically-
spaced range of p-values: 10 8, 10 7, 10 6, 10 5, 10 4, 10 3, and 10 2 (or a subset
if no SNP reached that significance level). We then used plink’s clumping procedure
(using the flag: –clump) with LD threshold r2 < 0:1 (using 10,000 randomly selected
unrelatedWB samples as a reference for LD structure) and physical distance threshold
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of >1MB. The selected SNPs were then used to calculate PGS for individuals in the
prediction sets, by summing the allelic counts weighted by their estimated effect sizes
(log of the odds ratios in the case of binary traits) using plink (using the flag: –
score). We calculated the incremental R2: we first determined in a regression of the
phenotype to the covariates, and then calculated the change in when including the
PGS as a predictor. For binary traits, we calculated incremental Nagelkerke’s R2.
Estimating heritability and genetic correlation.
We calculated SNP heritability across sex, age and SES groups for diastolic blood
pressures, BMI and years of schooling, respectively (as described in the section
“GWAS by sample characteristics”) as well as genetic correlations across pairs of
groups: we first performed GWAS using all unrelated WB individuals in each group.
We then used the GWAS summary statistics to perform LD-score regression with LD
scores computed from the 1000 Genomes European-ancestry samples [176]. We also
calculated genetic correlation between height and whole body water mass, using all
unrelated WB individuals for GWAS.
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2.6 Supplementary Materials
Overview of derived results
In the main text, we compare the prediction accuracies of polygenic scores (PGS)
based on a standard GWAS of unrelated individuals and a GWAS based on sibling
differences, for a number of traits. Here, we describe how this comparison is imple-
mented, and how indirect effects and assortative mating manifest in this comparison.
Matching standard and sib-based prediction accuracies. Current standard
GWAS are based on huge sample sizes, leading to less noisy estimates than are af-
forded by family association studies such as those based on sib differences, which are
typically much smaller. This difference in precision needs to be taken into account
in making comparisons between the prediction accuracy of scores derived from the
two approaches. We show that under a vanilla additive model with no assortative
mating, indirect effects, population structure (or other complications), and if the
standard GWAS is subsampled to a sample size
n  1
1 + (1  h2)(1  2sibs)n
pairs;
where npairs is the number of sib pairs, h2 is the heritability and sibs is the correlation
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in environmental effects experienced by siblings, the two study designs are expected to
have the same (out-of-sample) prediction accuracy (see section “Picking the sample
size of the standard GWAS sample to match the prediction accuracy of the score
based on the sib-GWAS”). This analytic result is not that useful in practice, however;
in particular, it requires prior knowledge about the extent to which environmental
effects correlate among siblings. Instead, we took an empirical approach to match
the prediction accuracies in the two approaches: following Wood et al. [36], we
subsampled the regular GWAS to match the median standard errors of the sib-GWAS.
As we show in section “Empirical matching of standard errors”, under our vanilla
model, we then expect near identical out-of-sample prediction accuracies for polygenic
scores derived from the two study designs.
Indirect parental effects. In the presence of indirect parental effects, the out-of-
sample prediction accuracy takes a simple form. For a polygenic score based on a





where  2 is the ratio of the variance in the trait due to both direct effects and indirect
effects of transmitted parental alleles over the total phenotypic variance; and c is a
term representing the noise to signal ratio in a standard GWAS. For the polygenic
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score based on sib-GWAS, we obtain





1 + c 2/h2
:
where 2 and 2 are the variances of random direct and indirect effects, respectively,
 is the correlation between direct and indirect effects, and h2 is the proportion of
the phenotypic variance explained by direct effects. Our results suggest that under
plausible conditions, the presence of indirect effects would lead to higher prediction
accuracy in a standard GWAS (after our sampling variance matching procedure).
This result holds whether direct and indirect effects are positively correlated, uncor-
related or even somewhat negatively correlated (Figure 2.10).
Assortative mating. We investigated several models of assortative mating
by simulation. Standard GWAS-based polygenic scores have greater prediction
accuracies than those based on sib-GWAS when the parental phenotypes are
positively correlated, and the reverse is true if they are negatively correlated
(Figure 2.11A,B). The relative difference in prediction accuracies of the two study
designs grows with the inclusion of more SNPs in the polygenic score model (Figure
2.11D,F).
In our analytic considerations, we ignored the ascertainment step of our study design,
in which it is decided which SNPs to include in the polygenic score. We assumed that
SNPs are pre-ascertained and that the set of ascertained SNPs includes all causal
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ones. In a subset of simulations, we implemented the ascertainment step based on
an independent simulated GWAS (see below). In both settings, we refer (somewhat
loosely therefore) to the regression on ascertained SNPs in a sample of unrelated
individuals as “standard GWAS” and the regression of the difference in phenotypes
on the difference in sib genotypes as “sib-GWAS.”
Picking the sample size of the standard GWAS sample to
match the prediction accuracy of the score based on the
sib-GWAS
We look for the sample size n of a standard GWAS performed on sample of unrelated
individuals such that, under our vanilla model, the resulting polygenic score has the
same (out-of-sample) prediction accuracy as the polygenic score obtained from a sib-
GWAS with sample size npairs. We begin by assuming that all causal sites i are
known; that they are unlinked; that they have only additive, direct effects on the
phenotype; and that there is no population stratification or assortative mating. We
first find the sampling variance of the effect size estimate for a single site obtained
from each of the two study designs. We will then examine (and ultimately match)
the prediction accuracy of the polygenic scores obtained from effect sizes estimated
in the estimation sets, ^ur; ^sib, on a new, independent prediction sample of unrelated
individuals f(x0; y0)g.
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Sampling error of the estimated effect size at a single site
Our model for the phenotypic value y is
y = g + e
where e is a Normally distributed environmental effect (which includes all sources of
random noise) and




where xi 2 f0; 1; 2g are random genotypes. The genotype is coded as the the number
of alleles with effect i carried by the individual at site i. Effect sizes  = fig are
treated as fixed parameters throughout (except when noted otherwise in the very last
step leading to eq. 2.22). We can rewrite our model to focus on the effect size at a
single site i:
y = 0 + ixi + i; (2.1)
where
i = g   ixi + e;
with variance
V ar[i] = V ar[g   ixi] + V ar[e] = V ar[y]  2i V ar[xi]
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In an OLS regression, the standard error for the effect of an allele at site i is
V ar[^uri ] =
V ar[i]
(n  1)V ar[xi] =
V ar[y]  2i V ar[xi]
(n  1)V ar[xi] ; (2.2)
where n is the sample size. In sib-GWAS, our model for site i is
y = s0 + ixi +i;
with variance
V ar[i] = V ar[g   ixi] + V ar[e] =
V ar[g] + 2i V ar[xi]  22i V ar[xi] + V ar[e]:









Plugging these back in, we obtain
V ar[i] = V ar[g]  2i V ar[xi] + 2V ar[e](1  sibs)
where sibs = Cor[eA; eB] is the correlation in environmental effects between sibs.
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The variance of the estimated effect size in sib-GWAS is therefore
V ar[^si ] =
V ar[i]
(npairs   1)V ar[xi] =
V ar[y]  2i V ar[xi] + V ar[e](1  2sibs)
(npairs   1)V ar[xi] : (2.3)
Sample size required for matched prediction accuracy
We measure prediction accuracy as the expected squared correlation between poly-
genic scores g^ and phenotypic values in an independent prediction set of unrelated

















We solve eq. 2.4 for a sample size n to be used for estimation of the polygenic score
in a standard GWAS that satisfies eq. 2.4. We note that if the vector of estimates ^
is given, then
Covf(x0;y0)g[y0; g^(x0)j^] = Covf(x0;y0)g[g(x0); g(x0) +
mX
i









To incorporate randomness both in the estimation set (summarized by the Multivari-
ate Normal distribution of ^) and the prediction set f(x0; y0)g, we apply the law of












Since for every i, we have
E[^uri ] = E[^
s








i = E^ur [Cov[y
0; g^ur(x0)j^ur]];
which turns the requirement of eq. 2.6 into
E^s [V arf(x0;y0)g[g^sib(x



















npairs   1 =
Pm
i V ar[y]  2i V ar[xi]Pm
i V ar[y]  2i V ar[xi] + V ar[e](1  2sibs)
;




1 + (1  h2)(1  2sibs) : (2.8)
Eq. 2.8 can in principle be applied to the estimation of sibs for a given trait, under
our model assumptions, and given an independent estimate of h2:
Empirical matching of standard errors
The result of eq. 2.8 is the same as we would obtain if we required
8i V ar[^sibi (xi)] != V ar[^uri (xsibi )] (2.9)
without taking into account randomness in the prediction set. In practice (and in the
results shown in the main text), we have no prior knowledge about sibs and instead









We note that the condition in eq. 2.9 is approximately met because, if we assume
that y is a highly polygenic trait where
8i 2i V ar[xi] << V ar[y];
then
8i V ar[^sibi (x)] = V ar[^uri (x)] =
D
V ar[xi]
where D is the same for sib-GWAS and standard GWAS estimates (given that a
sample of n is used), and approximately independent of i. Eq. 2.10 can be thought
of as a weighted-median ofD. In conclusion, the requirement of eq. 2.10 leads to equal
prediction accuracy of standard and sib-GWAS under the vanilla model assumptions.
We note further that in the main text (Figure 2.3), to follow common practice, we
use incremental R2 throughout rather than R2; However, as we show in Figure 2.15,
the use of R2 instead gives highly similar qualitative results.
Indirect parental effects
Distribution of the effect size estimate at a single site
We consider an additive model with direct effects as well as indirect parental effects,
assuming no interaction between the parents and the polygenic score of the children
and ignoring possible indirect effects of siblings on each other. We start by considering
the model
y = 0 + g + n+ e
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where g is the sum of direct effects in an individual with genotype (effect-allele count)














is the sum of parental indirect effects, with parental allele counts xi + ~xpi + ~xmi at
each site, where ~xmi is the untransmitted maternal effect allele count, and ~xpi the
untransmitted paternal effect allele count, with ~xmi ; ~xpi 2 f0; 1g. As we show, when
we choose the standard GWAS sample size n such that the effect size estimate
sampling errors match those of the sib-GWAS, the prediction accuracies of the two
polygenic scores differ in an independent sample: unless there is a large negative
correlation between indirect and direct effects, the polygenic score from standard
GWAS is expected to outperform the one based on sib-GWAS.
We first examine the distribution of an estimated effect size of xi on the phenotype.
The OLS regression for a single site in a standard GWAS follows eq. 2.1 and can be
rewritten as




i ) + i (2.11)
with
i = g + n+ e  (i + i)xi   i(~xpi + ~xmi ):
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By the assumption of no assortative mating or other population structure,
Cov[~xpi ; ~x
m
i ] = Cov[xi; ~x
m
i ] = Cov[xi; ~x
p
i ] = 0: (2.12)
It directly follows that under the generative model specified by eq. 2.11, the OLS
regression of y to xi and ~xpi + ~xmi is a regression involving two independent variables.
Therefore, ^uri is Normally distributed with expectation
E[^uri ] = i + i:
We next calculate the variance of ^uri . From assumption 2.12 and
V ar[~xmi + ~x
p
i ] = V ar[xi];
we obtain
V ar[i] = V ar[y]+(i+i)
2V ar[xi]+
2
i V ar[xi] 2Cov[g+n; (i+i)xi] 2Cov[n; i(~xmi +~xpi )] =
= V ar[y]  V ar[xi](2i + 2ii + 22i ):
Finally,
V ar[^uri ] =
V ar[i]
(n  1)V ar[xi] =
V ar[y]  V ar[xi](2i + 2ii + 22i )
(n  1)V ar[xi] :
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In sib regression, we have
y = g +e
since indirect parental effects cancel out when taking the difference between sibs (as
siblings have an equal parental effect allele count). Thus, the expected estimate is
the same as it was in the absence of indirect effects. Using the same considerations
as in section “Picking the sample size of the standard GWAS sample to match the
prediction accuracy of the score based on the sib-GWAS” for the variance in sib
differences, we obtain
^sibi  N(i;
V ar[g]  2i V ar[xi] + V ar[e](1  2sibs)
(npairs   1)V ar[xi] );
where sibs is again the correlation in environmental effects between siblings.
Polygenic score prediction accuracy
We now examine the difference in prediction accuracy of g^ur and g^sib after matching
V ar[^uri ]
!
= V ar[^sibi ] (2.13)
by choosing a standard GWAS sample size n that empirically satisfies the condition,
as we do in the main text (see also section “Empirical matching of standard errors”).
We can derive the expected prediction accuracy by averaging over both the estima-
tion set (which we again shorthand as the distribution of ^) and the prediction set
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where we approximate the expected prediction accuracy by its first-order Taylor ex-














and the denominator terms are
E^[V arf(x0;y0)g[y












2 + V ar[^i]): (2.17)
Plugging eq. 2.15,2.16,2.17 back into eq. 2.14, we obtain
E[R2]  (
Pm




















i V ar[xi](i + i)
2)2
~C + V ar[y]
Pm







i V ar[xi](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and the proportion of phenotypic variance explained by both direct and indirect
effects of transmitted alleles by
 2 :=
Pm
i V ar[xi](i + i)
2
V ar[y]
then the square of eq. 2.19 can be written as








i V ar[xi]V ar[^i]Pm
i V ar[xi](i + i)
2
:
Here, c can be thought of as a summary of the noise-to-signal ratio—with respect to
the signal coming from both direct and indirect effects of transmitted alleles. If we
treat effects  and  as random, treating results obtained thus far as conditional on 
and , and further assume that effects are i.i.d. across sites (implying, in particular,





























and thus eq. 2.20, in expectation, is:














i V ar[xi](i + i)
2
:
We examined the fit of this prediction to simulated data. Specifically, we ran simula-
tions to estimate effect sizes in a sib-GWAS and in a standard GWAS, after choosing
n to match their sampling variances. Finally, we used the polygenic scores to predict
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phenotypic values in a sample of unrelated individuals (see section “Simulations of
indirect effects” for further detail).
Figure 2.10A,C,D show the analytic result alongside simulation results, for different
correlation coefficients between indirect and direct effect sizes. Even in the absence
of a correlation between indirect and direct effect sizes, the polygenic score based on
standard GWAS outperforms the polygenic score based on sib-GWAS.
To understand this behavior and dependency of the R2sib
R2ur
ratio on other parameters,
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A few conclusions emerge from eq. 2.23 and from the accompanying simulations.
First, the sib-GWAS based polygenic score will outperform the standard GWAS-based
polygenic score only if direct and indirect effects are strongly negatively correlated
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(see Figure 2.10A-D for illustration). Second, the term
1 + c










i V ar[^i]V ar[xi]
h2
(2.24)
can be interpreted as the dependence on the noise-to-signal ratio (where the signals
are the proportions of phenotypic variance explained by direct and indirect effects of
transmitted alleles). For a given sampling variance (matched across the two study
designs), the extent of the signal will differ between standard GWAS and sib-GWAS.
Importantly, the sampling variance influences the ratio of prediction accuracies. If
indirect effects do not exist or make negligible contributions to the trait in question,
then the ratio of prediction accuracies is expected to be close to one. In the presence
of indirect effects, however, the magnitude of the deviation from 1 depends on the
relationship between direct and indirect effects (and their covariance) as well as on
the (matched) sampling variance. Simulations of several parameter combinations
suggest that the overall effect of this dependence on the noise-to-signal ratio is a
decrease in R2sibs/R2ur as noise increases; as more SNPs are included in the polygenic
scores, the advantage of the standard GWAS-based polygenic score over the sib-
GWAS based one grows larger (Figure 2.10E-H). These considerations provide a
possible interpretation for the patterns observed in Figure 2.3C-H of the main text.
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Simulations of indirect effects
For each set of simulated individuals (discovery, estimation and prediction sets), we
first simulated mother-father pairs, assigning parental alleles as Bernoulli(pi), where
pi denotes the effect allele frequency at site i. We then sampled the parental alleles
at random to generate offspring (one offspring per each mother-father pair to sim-
ulate a sample of unrelated individuals and two offspring to generate sibling pairs).
Phenotypes of the offspring were assigned under an additive model, sampling from a








(where xmi and xpi are the maternal and paternal effect allele counts, respectively)
and variance 2e ; representing the total variance of environmental effects. When there
is no correlation between direct and indirect effects, 2e = 1   h2   2 2 . Using this
approach, we generated a set of sibling pairs and estimated SNP effect sizes from
these simulated data using a sib-GWAS. We calculated n as follows: we simulated
sets of unrelated individuals with a range of sample sizes. In each set, we performed a
simple linear regression of the phenotypic values on the genotypes. We then estimated
a linear relationship between the inverse of the median standard error of effect size
estimates (as a dependent variable) and the square root of the sample size. Using
this linear relationship, we predicted the sample size for the unrelated set that gives
a median standard error equal to the median standard error of sib-GWAS effect size
estimates (n). Finally, we simulated a set of unrelated individuals with sample
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size n and compared the prediction accuracy (R2) of the polygenic score based on
standard GWAS on this sample with the one obtained from sib-GWAS.
We additionally investigated the effect of the number of SNPs included in the
polygenic scores. For this analysis, we sorted the SNPs based on the association
p-value obtained in an independent simulated set of unrelated individuals.
In these simulations, we used the following parameter values:
- The ratio of the phenotypic variance accounted for by direct effects versus by indirect
effects (h2/ 2 ): 5
- The phenotypic variance explained by offspring and parental alleles, given no cor-
relation between direct and indirect effects (h2 + 2 2 ): 0.25 or 0.5
- The ratio of the variance of direct effects to the variance of indirect effects (2/2):
5
- Allele frequencies are drawn from a truncated exponential distribution, truncated
on the left such that the minimum allele frequency is 1%.
- The number of loci, assumed independent (i.e., in linkage equilibrium): 100 (all
causal), or 10,000 (all causal) or 10,000 (20% causal)














where  is the correlation between direct and indirect effect sizes. Effects sizes were
then re-scaled to satisfy Pmi 22i pi(1   pi) = h2 and Pmi 22i pi(1   pi) =  2 . Effects
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were set to 0 for non-causal loci.
- The number of sibling pairs for sib GWAS: 10,000
- The number of unrelated individuals for prediction: 10,000
- The number of unrelated individuals for discovery GWAS (i.e., to decide which
SNPs to include): 20,000
- Number of iterations used to estimate n and R2 for a given set of parameters: 10
Assortative mating
We consider assortative mating with regard to a phenotype, whereby the parents of
individuals were more likely to mate if they were similar with respect to that pheno-
type. This process generates a correlation between genetic variants that contribute
to the phenotype (i.e., linkage disequilibrium). Consequently, in a standard GWAS,
the effect sizes of causal SNPs will partially capture the effect of other causal SNPs
as well. Estimated effect sizes are thus expected to be inflated under positive assor-
tative mating (mating of similar individuals) and deflated under negative assortative
mating (mating of dissimilar individuals). In turn, in a sib-GWAS, the estimates are
in expectation unaffected by assortative mating, because genetic differences between
siblings arise from random Mendelian segregation in the parents.
Simulations of assortative mating
We used simulations to examine the phenotypic prediction accuracies of polygenic
scores based on sib- and standard GWAS under a model with assortative mating
(assuming no indirect effects or population stratification beyond assortative mating);
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this end, we considered a sample of unrelated individuals, varying the degree of
correlation between parental phenotypes a. Similar to our simulations for indirect
effects (section “Simulations of indirect effects”), we first simulated the estimation
procedure in a sibling-based and in a standard GWAS (with sample size n). We
then computed the prediction accuracy R2 in an independent sample of unrelated
individuals (see “Further simulation details” below).
We first considered the simple case of a single generation of assortative mating.
In the presence of positive assortative mating (a > 0), polygenic scores based on
standard GWAS outperform those based on sib-GWAS, whereas the opposite is true
in the case of negative assortative mating (a < 0) (Figure 2.11A). In simulations
of two generations of assortative mating, the gap between the prediction accuracies
of scores based on standard and sib-GWAS (Figure 2.11B) widens, suggesting
that our qualitative findings apply to scenarios of sustained assortative mating as well.
We further investigated prediction accuracy as a function of the number of SNPs
included in the polygenic scores, by progressively increasing the p-value threshold,
using p-values obtained from an independent GWAS in unrelated samples (similar
to our analysis in Figure 2.3). We considered two genetic architectures scenarios:
(i) in which all SNPs are causal and (ii) the case in which 20% of of SNPs are
causal (leading polygenic scores to include non-causal SNPs). Under both scenarios,
the gap in prediction accuracies between standard and sib-GWAS grows with the
number of SNPs (Figure 2.11C-F).
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Further simulation details. We simulated parental and offspring alleles as de-
scribed for indirect effects in section “Simulations of indirect effects”. To mimic
assortative mating between parents, we first simulated i.i.d. genotypes (with effect
allele counts xi at each SNP i) and randomly assigned “mother” and “father” labels








where i is the effect size of SNP i, and h2 is the heritability. The same model was
used to generate offspring phenotypes.
To induce a given correlation between parental phenotypes, a (mimicking the conse-
quence of the assortative mating process), we paired mothers and fathers as follows:














where ym and yp are the average phenotypes of mothers and fathers, respectively,
ym and yp are the standard deviation of the phenotypes of mothers and fathers,
respectively. We then sorted the mothers and fathers sets such that the ranks of
values in ym and yp match the ranks of values in um and up, respectively, to obtain
cor(ym; yp)  cor(um; up) = a. In the case of two generations of assortative mating,
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we simulated the generation of the grandparents similarly. We compared the perfor-
mance of polygenic scores based on standard and sib-GWAS as described in section
“Simulations of indirect effects”. In the simulations, we used the following parameter
values:
- Heritability under random mating: 0.5
- The number of loci, assumed independent (i.e., in linkage equilibrium) under random
mating: 10,000 (all causal) or 10,000 (20% causal)
- Allele frequencies, p, drawn from a truncated exponential distribution, truncated
on the left such that the minimum allele frequency is 1%.
- SNP effect sizes set to 0 for non-causal loci and drawn as i  N(0; 2), choosing
2 to satisfy Pmi 22i pi(1  pi) = h2 for causal loci.
- The number of sibling pairs for sib GWAS: 10,000
- The number of unrelated individuals for prediction: 10,000
- The number of unrelated individuals for discovery GWAS (i.e., to decide which
SNPs to include in the polygenic score): 20,000
- The number of iterations used to estimate n and R2 for a given set of parameters:
10
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Table 2.1: Traits analyzed and their corresponding data fields in UK Biobank. For diastolic
blood pressure, in addition to the raw measurements, we used medication data to adjust the
blood pressure levels. For hand grip strength, we used the measurements for both hands.
In parentheses are units of measurements.
Trait Description UKB data field
Age at first sex Self-reported age at first sexual intercourse (years) 2139
Alcohol intake frequency Self-reported category, encoded as an integer: 1, “Daily or 1558
almost daily”; 2, “Three or four times a week”; 3, “Once
or twice a week”; 4, “One to three times a month”;
5, “Special occasions only”; 6, “Never”
Basal metabolic rate Estimated from body composition impedance measurements (KJ) 23105
Birth weight Self-reported birth-weight (Kg) 20022
Body mass index Constructed from height and weight measurements (Kg/m2) 21001
Diastolic blood pressure Measured using automated devices (mmHg); values are adjusted 4079, 6153, 6177
for medicine use (see Materials and Methods)
Fluid intelligence Unweighted sum of the number of correct answers given to 20016
13 fluid intelligence questions
Forced vital capacity Calculated from breath spirometry (liters) 3062
Hair color Self-reported category, encoded as an integer: 1, “Blonde”; 1747
2, “Red”; 3, “Light brown”; 4, “Dark brown”; 5, “Black”;
none, “Other”
Hand grip strength Measured right and left hand isometric grip strength (Kg) 46, 47
Height Measured standing height (cm) 50
Hip circumference Measured hip circumference (cm) 49
Household income Self-reported average total annual household income before tax 738
category, encoded as an integer: 1, “Less than $18; 000”;
2, “$18; 000 to $30; 999”; 3, “$31; 000 to $51; 999”;
4, “$52; 000 to $100; 000”; 5, “Greater than $100; 000”
Neuroticism score Derived summary score, based on participants’ responses 20127
to 12 neurotic behaviour-related questions
Overall health rating Self-reported category, encoded as an integer: 1, “Excellent”; 2178
2, “Good”; 3, “Fair”; 4, “Poor”
Pack years of smoking Calculated for individuals who have ever smoked as the number 20161
of cigarettes smoked per day, divided by twenty, multiplied
by the number of years of smoking (years)
Pulse rate Measured during the automated blood pressure readings (bpm) 102
Skin color Self-reported category, encoded as an integer: 1, “Very fair”; 2, 1717
“Fair”; 3, “Light olive”; 4, “Dark olive”; 5, “Brown”; 6, “Black”
Waist circumference Measured waist circumference (cm) 48
Whole body fat mass Estimated from body composition impedance measurements (Kg) 23100
Whole body water mass Estimated from body composition impedance measurements (Kg) 23102
Years of schooling Education qualifications converted to years (see Table 2.4) 6138
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Table 2.2: Genetic correlations across samples that vary by a study characteristic. Numbers
are genetic correlations estimated using LD score regression for BMI, years of schooling and
diastolic blood pressure, across samples stratified by age, Townsend deprivation index (a
measure of socioeconomic status, SES), and sex, respectively. ‘Q’ denotes quartile of age
or SES.
Trait/characteristic Pair of strata Genetic correlation (s.e.)
(Q1,Q2) 0.93 (0.036)
(Q1,Q3) 0.95 (0.035)










Diastolic blood pressure/Sex (male,female) 0.93 (0.031)
142
Table 2.3: Sample sizes for siblings and unrelated sets. As described in Figure 2.3A,
for the comparison of prediction accuracies of polygenic scores based on standard and
sib-GWAS, we first ascertain SNPs in a large sample of unrelated individuals (“Unrelated-
discovery”) and then estimate the effect of these SNPs with a standard regression us-
ing unrelated individuals (“Unrelated-n*”) and, independently, using sib-regression (in the
“Siblings” set). Finally, we used the polygenic scores for prediction in a third sample of
unrelated individuals (“Unrelated-prediction”). This table shows sample sizes used for each
set across the traits analyzed.
Trait Siblings (pairs) Unrelateds-discovery Unrelateds-n* Unrelateds-prediction
Age at first sex 13677 244929 8843 27214
Alcohol intake frequency 17288 276872 10977 30763
Basal metabolic rate 16802 269728 13490 29969
Birth weight 6753 159237 5608 17693
Body mass index 17223 274887 12377 30543
Diastolic blood pressure 14795 253343 9424 28149
Fluid intelligence 3889 101070 2928 11229
Forced vital capacity 14611 252859 9731 28095
Hair color 16859 272151 11825 30238
Hand grip strength 17070 275067 10884 30563
Height 17248 270065 18085 30007
Hip circumference 17254 275957 11615 30661
Household income 13244 239274 8787 26585
Neuroticism score 11759 227111 6825 25234
Overall health rating 17195 276628 10365 30736
Pack years of smoking 2307 85626 1604 9513
Pulse rate 14791 253877 8790 28208
Skin color 16903 274150 10342 30461
Waist circumference 17257 275863 11757 30651
Whole body fat mass 16750 270569 12046 30063
Whole body water mass 16804 269694 13535 29965
Years of schooling 17041 273599 11873 30399
Simulated trait 1 17305 276731 11362 30747
Simulated trait 2 17305 276382 11749 30709
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Table 2.4: Academic degree to years of schooling conversion table. The qualifications were
converted to years of schooling following Okbay et al. [173]
Qualifications (UKB data field 6138) Years of schooling
College or University degree 20
NVQ or HND or HNC or equivalent 19
Other professional qualifications eg: nursing, teaching 15
A levels/AS levels or equivalent 13
O levels/GCSEs or equivalent 10
CSEs or equivalent 10
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Figure 2.4: Variable prediction accuracy (measured as R2) even within an ancestry group.
This figure mirrors Figure 2.1 of the main text, except for the y-axis showing are R2
values, rather than incremental R2. Each box and whiskers plot was computed based
on twenty choices of estimation and prediction sets. Thick horizontal lines denote the
medians. (A,C,E) The polygenic scores were estimated in large samples of unrelated
“White British” (WB) individuals. Phenotypes were then predicted in distinct sets of
unrelated WB individuals, stratified by sex (A), age (C) or Townsend deprivation index, a
measure of SES (E). (B,D,F) Same as in A,C,E, but here the polygenic scores are based
on a GWAS in a sample limited to one sex or to one age or SES stratum. When the GWAS
is performed in the sex or stratum that shows higher prediction accuracy in A,C,E (female,
young, low SES), the qualitative trend is the same, but when the GWAS is performed in
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Figure 2.5: Dependence on the number of SNPs included in the polygenic score. This figure
extends Figure 2.1 of the main text, showing the prediction accuracies as a function of
the p-value threshold for inclusion of a SNP in the polygenic score. The higher the p-value
threshold is, the more SNPs are included. Shown are incremental R2 values in different
prediction sets. Points and error bars are mean and central 80% range computed based
on twenty choices of estimation and prediction sets. (A,D,G). The polygenic scores were
estimated in large samples of unrelated “White British” (WB) individuals. Phenotypes
were then predicted in distinct samples of unrelated WB individuals, stratified by sex (A),
age (D) or Townsend deprivation index, a measure of SES (G). (B-I) Same as in A,D,G,
but here the polygenic scores are based on a GWAS in a sample limited to one sex, age or
SES group. The trends shown in Figure 2.1 of the main text are for p-value threshold of












































































































































































Figure 2.6: Estimating mean effect size across strata. SNPs were ascertained in large
samples of unrelated “White British” (WB) individuals. The effects of trait-increasing
alleles were then re-estimated in an independent set of unrelated WB individuals (that
were excluded from the original GWAS) stratified by sex for diastolic blood pressure (A),
by age for BMI (B) and by Townsend deprivation index, a measure of SES for years of
schooling (C). Points and error bars are mean and central 80% range computed based on
twenty choices of ascertainment and estimation sets, plotted as a function of the p-value
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Figure 2.7: Variable prediction accuracy within an ancestry: sensitivity to controls for
population structure. This figure mirrors the panels in Figure 2.5, except that here,
the standard GWAS estimates were obtained from a linear mixed model (LMM). Shown
are the prediction accuracies, measured as incremental R2, as a function of the p-value
threshold for inclusion of a SNP in the polygenic score. Points and error bars are mean and
central 80% range computed based on twenty choices of estimation and prediction sets. The
polygenic scores are based on a GWAS in a sample limited to one sex, age or SES group.
Phenotypes are then predicted in distinct samples of unrelated individuals, stratified by sex
(A), age (B) or Townsend deprivation index, a measure of SES (C). The qualitative trends
are similar to those in Figure 2.5, which uses a standard linear regression with PCs as a
control for population structure when testing for an association between the phenotypes and
genotypes. The similarity suggests that the observed differences in prediction accuracies







































Figure 2.8: Comparison of siblings and unrelated individuals in the UK Biobank with
respect to age, SES, and sex ratio. Panels show the distribution of Townsend deprivation
index, a measure of SES (A), the age distribution (B), and the proportion of males (C)
for the siblings and unrelated sets used in the analysis described for Figure 2.3 of the
main text. For each sibling pair, one sibling was randomly selected for these comparisons.
The asterisk symbol marks a significant difference at the 1% level between siblings and
unrelated individuals, as assessed by a Mann-Whitney test. SES and age distributions are
quite similar in siblings and unrelated sets, whereas the proportion of males is significantly





































































































































Figure 2.9: Comparison of siblings and unrelated individuals in the UK Biobank with
respect to population structure. Panels show the distribution of PCs (principal components
of the genotype data) for the siblings and unrelated sets used in the analysis described for
Figure 2.3 of the main text. For each sibling pair, one sibling was randomly selected
for these comparisons. The asterisk symbol marks a significant difference at the 1% level
between siblings and unrelated individuals, as assessed by a Mann-Whitney test. Despite
slight but significant differences, siblings and unrelated sets are broadly similar with respect



























−1.0 −0.5 0.0 0.5 1.0
    Correlation between













−1.0 −0.5 0.0 0.5 1.0
    Correlation between












































0 2500 5000 7500 10000
Number of SNPs
R2





−1.0 −0.5 0.0 0.5 1.0
    Correlation between






−1.0 −0.5 0.0 0.5 1.0
    Correlation between








noise than panel A
less polygenic
than panel A
Figure 2.10: Simulation results for polygenic scores based on standard GWAS and sib-
GWAS in the presence of indirect effects. (A,B) Simulation results as a function of the
correlation between direct and indirect effects, . Simulations were performed with h2 = 0:5,
2 = 0:1, and 2/2 = 5. The size of the estimation set in the sib-GWAS is 10,000, and
the size of the estimation set in the standard GWAS is chosen to match sampling variances
between the two study designs. The polygenic scores is based on 10,000 causal loci; its
performance was evaluated in an independent set of 10,000 unrelated individuals. As long
as direct and indirect effects are not strongly negatively correlated, out-of-sample prediction
accuracy is higher for the polygenic scores based on standard GWAS. (C) Same as (A)
but with three-fold greater environmental noise. (D) Same as (A) but with 100 causal loci.
In (A-D) points are mean  2 SD in 10 simulation iterations. Solid lines are values based
on analytic expressions derived in section “Polygenic score prediction accuracy”. (E-H)
Simulations results, with the same parameters as in (A) but  = 0:5, as a function of the
number of SNPs included in the polygenic scores, with all loci being causal (E,F), or with
20% of loci being causal (G,H). SNPs are added in an increasing order of their association
p-value in an independent set of 20,000 unrelated individuals. In both cases, the ratio of
prediction accuracies of polygenic scores based on sib- versus standard GWAS becomes
smaller with the inclusion of more weakly associated SNPs, a behavior qualitatively similar
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Figure 2.11: Simulation results for polygenic scores based on standard GWAS and sib-
GWAS in the presence of assortative mating. (A) Simulation results as a function of
the approximate correlation between parental phenotypes, a. Simulations were performed
with 2 = 0:5 under random mating. The size of the estimation set in the sib-GWAS is
10,000, and the size of the estimation set in the standard GWAS is chosen to match sam-
pling variances between the two study designs. The polygenic scores is based on 10,000
causal loci; its performance was evaluated in an independent set of 10,000 unrelated indi-
viduals. Standard-GWAS based polygenic scores outperforms (underperforms) sib-GWAS
based polygenic scores under positive (negative) assortative mating. (B) Ratio of predic-
tion accuracies of the polygenic scores based on sib- versus standard GWAS, as a function
of a, for two sets of simulations with one or two generations of assortative mating, with
same parameters as in (A). (C-F) Simulations results, with the same parameters as in (A)
but a = 0:5, as a function of the number of SNPs included in the polygenic score, with
all loci being causal (C,D), or with 20% of loci being causal (E,F). SNPs are added in the
order of their association p-value in an independent set of 20,000 unrelated individuals. In
both cases, the ratio of prediction accuracies for scores based on sib-GWAS versus standard
GWAS becomes smaller with the inclusion of more weakly associated SNPs, a behavior that
is qualitatively similar to observations in Figure 2.3 in the main text. Points are mean 
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Figure 2.12: Comparison of prediction accuracies of polygenic scores based on standard
and sib-GWAS matched for sex ratio. This figure mirrors Figure 2.3B of the main text,
but here the samples of siblings and unrelated individuals used in the analysis are matched
for sex ratio. Results are shown for diastolic blood pressure, as the prediction accuracy
differed between sexes (Figure 2.1), the related phenotype of pulse rate, and a subset of
the traits for which the prediction accuracy varied by GWAS design (Figure 2.3B). Small
points show the ratio of the prediction accuracies in the two designs across 10 iterations;
in each iteration, we resample sets of unrelated individuals to constitute three sets: for
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Figure 2.13: Prediction accuracy of polygenic scores based on sib-and standard GWAS, for
a range of traits. This figure complements Figure 2.3C-H of the main text, showing the
results of the study design depicted in Figure 2.3A for all traits presented in Figure 2.3.
As described for Figure 2.3, we randomly divided unrelated individuals to constitute three
non-overlapping sets for discovery, estimation and prediction. Small points correspond to
10 iterations of resmapling these three sets. The prediction accuracy is plotted as a function



























































































































Figure 2.14: Variable prediction accuracy within an ancestry group for binary education
phenotypes. Shown are incremental Nagelkerke’s R2 for two binary education phenotypes,
attained a college degree or not (A), and attained any degree or not (B). The polygenic
scores are estimated in large samples of unrelated individuals. Phenotypes are then pre-
dicted in distinct samples of unrelated individuals, stratified by Townsend deprivation index,
a measure of SES. Points and error bars are mean and central 80% range computed based
on twenty choices of estimation and prediction sets, plotted as a function of the p-value
threshold (with p-values obtained in the original GWAS).
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Figure 2.15: Comparison of prediction accuracies of polygenic scores (measured as R2)
based on standard and sib-GWAS. This figure mirrors Figure 2.3B of the main text,
but here we first residualized the phenotypes on covariates, and then ran the same pipeline
described as that used to generate Figure 2.3B on the residuals without further adjustment
for covariates in the GWAS or prediction evaluation. Thus, this figure relates more directly
to the analytical derivation in section “Picking the sample size of the standard GWAS
sample to match the prediction accuracy of the score based on the sib-GWAS”. However,
the results in Figure 2.3B and here are qualitatively similar. Small points show the ratio
of the prediction accuracies in the two designs across 10 iterations; in each iteration, we
resample sets of unrelated individuals to constitute three sets: for discovery, estimation and
prediction. Large points show mean values.
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Future directions
In Chapter 1, I presented results on viability selection using the two large data
sets, the GERA cohort and the UK Biobank, testing whether the frequency of an
allele (or set of alleles identified in GWAS to influence variation in diseases and an-
thropomorphic traits) differs across individuals born at different times accounting for
variation in ancestry and batch effects. Although these cohorts include a wide range
of ages, they often lack younger than middle-aged individuals, which are of particular
importance to detect variants influencing survival early in life. Incorporating young
individuals recruited for studies of childhood diseases or longitudinal studies, such as
MSSNG [177] and ALSPAC [178] data sets, could close this gap.
Another complementary approach is to analyze nuclear families to investigate the
viability effect of variants during early development and embryogenesis. These can be
identified, for instance, by looking at transmission distortion in parent-offspring trios:
for a bi-allelic SNP, an advantageous allele will appear over-transmitted (compared
to the other allele) from the parents to the offspring. To this end, a transmission
distortion test (TDT) could be applied to human pedigrees [179], such as Framingham
Heart Study [180] (e.g., Meyer et al. [117]). This approach will become more powerful
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with the collection of more family-based data in the future; current sample sizes (e.g.,
10,000 trios in MSSNG) are much smaller compared to GWAS which are reaching
sample sizes on the scale of a million.
This work is one of the first to utilize the genetic data that are now available through
biomedical studies, in order to directly observe the ongoing evolutionary change in
contemporary humans. The application of approaches such as ours to the millions
of samples in the pipeline (such as the Precision Medicine Initiative program [114])
will provide a more comprehensive picture of viability selection. Moving forward,
studies should consider other components of fitness as well, fertility and inclusive
fitness, ideally with large scale multi-generational longitudinal designs to tract some
of the long-standing questions in human evolutionary genetics, such as: How, and
to what extent, does natural selection shape common genetic variation? Such a goal
is reminiscent of Lewontin’s suggestion in 1968 for investigating natural selection on
ABO blood groups [80]: “What we need to do is a brute force, unsophisticated, simple
study in which you take 300,000 or 400,000 … offspring at birth, blood-type them for
ABO, … keep track of them until they get to be about 35 and record when each of
them dies, if he does, and when each of them has an offspring.”
One thing Lewontin did not foresee is the importance of subtle population structure,
among other challenges involved with the analyses enabled by large-scale data sets.
In Chapter 2, I discussed underappreciated factors influencing the portability of
polygenic scores (PGS), which are increasingly being used in diverse disciplines such
as human genetics, social sciences and evolutionary biology. Previous studies have
mainly focused on the lack of portability across genetic ancestry groups, largely at-
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tributing this limitation to distinct demographic histories. However, we show that in
addition to these considerations, factors such as sample characteristics (e.g., age, sex,
socioeconomic status) and GWAS study design contribute to the prediction accuracy
of PGS, and consequently to their portability between as well as within ancestry
groups. Given these increasing uses, there is a pressing need to quantify the rela-
tive contribution of these factors to PGS prediction accuracy and determine the axes
along which PGS are more or less portable.
One direction is to investigate whether, and by how much, portability across an-
cestries is improved if PGS are based on fine-mapped loci (i.e., loci determined as
causal within a genomic region detected in GWAS, e.g., [181]) compared to when
based on tag SNPs alone. This effort will be informative about the contribution of
linkage disequilibrium differences to portability across human populations. Another
direction is to study portability across groups stratified by both ancestry and sample
characteristics. Consider the example of years of schooling: in Chapter 2 we demon-
strated that PGS prediction accuracy is variable within White British (WB) samples
in the UK Biobank depending on their socioeconomic status (SES). This analysis can
be extended to include prediction samples from other ancestries to evaluate by how
much the drop in portability across ancestries is mediated by SES, e.g., by perform-
ing GWAS in low and high SES WB individuals and making prediction in low and
high SES WB as well as low and high SES East Asian ancestry individuals. Lastly,
portability can be evaluated when PGS use direct genetic effects only, dissected using
family-based approaches (such as sibling-GWAS presented here).
In summary, for GWAS results to be reliably used for the study of polygenic adapta-
159
tion and phenotypic prediction will require novel approaches to characterize different
sources of bias in GWAS that contribute to these analyses (e.g., [33, 162]). Expanding
efforts to collect large-scale data bases from related individuals would be particularly
useful in this regard.
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Appendix
In this section I list the works that I contributed as a co-author and/or were not
directly relevant to the topic of this thesis to be presented as a chapter.
• Entropic forces drive self-organization and membrane fusion by
SNARE proteins
(Published under Mostafavi et al. PNAS 2017)
Abstract
SNARE proteins are the core of the cell’s fusion machinery and mediate virtu-
ally all known intracellular membrane fusion reactions on which exocytosis and
trafficking depend. Fusion is catalyzed when vesicle-associated v-SNAREs form
trans-SNARE complexes (“SNAREpins”) with target membrane-associated t-
SNAREs, a zippering-like process releasing 65 kT per SNAREpin. Fusion
requires several SNAREpins, but how they cooperate is unknown and reports
of the number required vary widely. To capture the collective behavior on the
long timescales of fusion, we developed a highly coarse-grained model that re-
tains key biophysical SNARE properties such as the zippering energy landscape
177
and the surface charge distribution. In simulations the 65-kT zippering energy
was almost entirely dissipated, with fully assembled SNARE motifs but uncom-
plexed linker domains. The SNAREpins self-organized into a circular cluster
at the fusion site, driven by entropic forces that originate in steric–electrostatic
interactions among SNAREpins and membranes. Cooperative entropic forces
expanded the cluster and pulled the membranes together at the center point
with high force. We find that there is no critical number of SNAREs required for
fusion, but instead the fusion rate increases rapidly with the number of SNARE-
pins due to increasing entropic forces. We hypothesize that this principle finds
physiological use to boost fusion rates to meet the demanding timescales of neu-
rotransmission, exploiting the large number of v-SNAREs available in synaptic
vesicles. Once in an unfettered cluster, we estimate 15 SNAREpins are re-
quired for fusion within the 1-ms timescale of neurotransmitter release.
This is my work at Columbia’s Chemical Engineering department before
joining the Przeworski lab.
• Reduced signal for polygenic adaptation of height in UK Biobank
(Published under Berg et al. eLife 2019)
Abstract
Several recent papers have reported strong signals of selection on European
polygenic height scores. These analyses used height effect estimates from the
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GIANT consortium and replication studies. Here, we describe a new analysis
based on the the UK Biobank (UKB), a large, independent dataset. We find
that the signals of selection using UKB effect estimates are strongly attenuated
or absent. We also provide evidence that previous analyses were confounded by
population stratification. Therefore, the conclusion of strong polygenic adapta-
tion now lacks support. Moreover, these discrepancies highlight (1) that meth-
ods for correcting for population stratification in GWAS may not always be
sufficient for polygenic trait analyses, and (2) that claims of differences in poly-
genic scores between populations should be treated with caution until these
issues are better understood.
My main contribution to this work was to perform a sibling-based GWAS for
height, as well as to curate sets of independent height-associated SNPs for
polygenic score analyses.
• Measuring intolerance to mutation in human genetics
(Published under Fuller et al. Nat. Genet. 2019)
Abstract
In numerous applications, from working with animal models to mapping the
genetic basis of human disease susceptibility, knowing whether a single disrupt-
ing mutation in a gene is likely to be deleterious is useful. With this goal in
mind, a number of measures have been developed to identify genes in which
179
protein-truncating variants (PTVs), or other types of mutations, are absent
or kept at very low frequency in large population samples—genes that appear
‘intolerant’ to mutation. One measure in particular, the probability of being
loss-of-function intolerant (pLI), has been widely adopted. This measure was
designed to classify genes into three categories, null, recessive and haploinsuf-
ficient, on the basis of the contrast between observed and expected numbers
of PTVs. Such population-genetic approaches can be useful in many applica-
tions. As we clarify, however, they reflect the strength of selection acting on
heterozygotes and not dominance or haploinsufficiency.
In this perspective paper, I contributed to the structure and writing of the piece,
as well as to the study design applying the pLI measure to simulated data.
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